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INTRODUCTION 
―Cured yesterday of my disease, I died last night of my physician‖ 
-Matthew prior 
Adverse Drug reactions is defined as ―Any noxious change which is suspected 
to be due to a drug, occurs at doses normally used in man , requires treatment or 
decrease in dose  or indicated caution in the future use of the same drug‖[1]. It has been 
estimated that only 6 to 10% of all the ADRs are reported. The overall approximate 
hospitalization due to ADRs is estimated to be 5% ranging from 2% to 20%. At least 
one in 10 to 20% of the hospitalized patients develop ADR
 [2]
. ADRs ranks fifth 
among all causes of death and its management contributes from 5 to 10% of hospital 
costs
 [3]
. Pharmacovigilance is the science and activities relating to the detection, 
assessment, understanding and prevention of adverse effects or any other medicine 
related problem
 [4]
.  It involves the study of drug-related reactions and making warning 
or withdrawal recommendations for pharmaceutical agents. In addition to preserving 
the safety and quality of life for the patient, Pharmacovigilance can represent a cost 
effective treatment to the patient and the health care institution. Pharmacovigilance in 
India is rate less than 1% against the world rate of 5%
 [5]
.Studies have shown that 
between 20% and 80% of ADEs and ADRs are preventable with the majority of latter 
studies showing around 60- 70% preventability
[6]
. 
All the tropical diseases have alternate drugs for their management. But, ASV 
is the only lifesaving yet dangerous treatment for snake bite. The reactions due to 
ASV are indeed unpredictable and underreported. The irrationality in its usage is 
usually due to lack of fear and experience. Moreover the cost and the adverse reaction 
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is mostly taken under consideration. In various parts of the world, there is a continuing 
crisis in the production, deployment and accessibility of antivenom. It is therefore a 
matter of great urgency to promote international collaboration—best coordinated by 
the World Health Organization—involving national and regional health organizations 
and diverse public & private partnerships in order to accomplish the following goals: 
(1) to gather accurate epidemiological information on the impact and characteristics of 
snake bite envenoming in many regions, using properly designed community studies; 
and (2) to provide effective and safe antivenom in those regions who need them. 
Above all the current focus on the individual variation in the efficacy and safety of 
ASV are brought into consideration. Many of the physicians nowadays do not rely 
mainly on the polyvalent ASV in India as they do not cover all the important snake 
species. Thus, the utilization pattern tends to vary in different regions. 
Snakebite is a terrifying experience at an individual level, as in India the low 
socio-economic people are mostly affected in all age groups. The concept of ―Big 4‖ 
had been on the benefit of the laypersons to describe more about the snakes. ASV 
being the only mode of treatment is also derived from the snakes of the ―Big 4‖. Since 
the management in paediatric to elderly has no dose variations, the efficacy and safety 
is looked upon the overall population. The most important aspect of the effective 
management of snake bite is the outcome of the patient.  The cost procured in the 
management of snake bite ranges from Rs.5, 000 to 2, 00,000. While a painful death is 
how Hollywood typically portrays snakebites in film, the reality is far more 
distressing that most people could imagine and the consequences are often social 
stigmatization. Snakebite can have devastating physiological effects on the human 
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body, because snake venom toxins have evolved to target almost every type of bodily 
function or body part.  
Only by the year 2009, snake bite was included in the mist of neglected disease 
by WHO. The past decade has seen a wide range of studies on snake bite. But the 
clarity on the utilization pattern and adverse reactions are still underreported. There 
are very limited manufacturers of ASV in India. Only polyvalent ASV is available in 
India. There is always a debate on the incidence of adverse reactions due to ASV. So 
the present study brings about the analysis of adverse reactions and its difference in 
various ASV manufacturers used in the study area. Also the present study had focused 
on three study area among which the epidemiology of snake bite in Perambalur and 
Ariyalur has to be studied as there are no studies reported so far. The Recent views on 
the safety and efficacy of the ASV among different manufacturer comes into 
existence. There are many in-vitro studies which revealed mixed results on the 
different manufactures. So the present study was done to analyze the ADR and 
compare their safety profile among the manufacturers used in three districts of 
Tamilnadu. 
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OBJECTIVES OF THE STUDY 
PRIMARY OBJECTIVE 
 To analyze the prevalence of the Adverse Drug Reactions and dosage 
patterns of Anti-Snake Venom.  
 To compare the safety profile with regard to Anti-Snake Venom among 
three Manufacturers.  
SECONDARY OBJECTIVE 
 To perform causality and severity assessment of the Adverse Drug 
Reactions. 
 To Study the Demographic and clinical profile of snake bite cases. 
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REVIEW OF LITERATURE 
Comprehensively, around 4,21,000 envenoming and 20,000 deaths due to 
snake bite occur every year. Based on the fact that envenoming occurs in about one in 
every four snakebite, between 1.2 million and 5.5 million snakebites could occur 
annually
 [7]
. The first national survey in India, the Million Death Study was undertaken 
in 2010 by the Registrar General of India and the Centre for Global Health Research 
gives an estimate of 46,000 annual deaths by snakebite in the country whereas the 
Government of India‘s Central Bureau of Health Intelligence reports only 1,350 
deaths each year for the period 2004 to 2009. This massive statistical disparity has 
important and urgent implications. The deficiency in surveillance and the paucity of 
properly designed epidemiological studies explain why the impact of this important 
public health problem has remained for so long unrecognized and neglected. 
Snakes are poikilothermic carnivorous reptiles distributed in almost all the 
earth‘s surface except in the Antarctica, Greenland, Iceland and New Zealand. Among 
the Indian states the highest incidence seems to be in Maharashtra followed by Kerala, 
Tamilnadu, Uttarpradesh and West Bengal. Most of those who died from snake bite in 
developing countries like India are agriculturalist and manual laborers who, by the 
very nature of their work, the environment where they work in and their habit of 
working with bare hands are short implements and of walking bare footed are more 
likely to suffer snake bite. By destroying forests for creating agricultural land, the prey 
base of the snake (that is frogs and rats) has increased. The rice belts which harbor 
millions of rats, attract a lot of snakes. The number of snakes per acre in a rice belt is 
abnormally high when compared to the natural population in the forest. Humans go 
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into the belt every morning and come out in the evening, just the time when snakes are 
active. Thus the chance of an encounter between farmer and snake is very high. As 
more areas are inhabited at the periphery of towns, even there the chances of human / 
snake interaction increase.  
Cobras flourish as long as there are rice fields; there they feed mainly on the 
mole rat (varapu eli in Tamil), live and lay their eggs in the rat burrow networks. 
Kraits also get by very well in rice belts because they like the plentiful small rodents 
such as the field mouse (sundeli in Tamil) and rock mouse (kallu eli in Tamil). Kraits 
are also found in the mounds of earth and rubble near wells. The Russell‘s viper lives 
in the rocky outcrops and hedgerows of cactus and other bushes which often form the 
boundaries of agricultural land. There, on the high ground, they have a plentiful 
supply of common gerbil (velleli in Tamil) which is also attracted to the food, humans 
provide by their farming activities.  They belong to poorer sections of society and in 
most cases, are the sole bread winner of the family. When they die, a sudden death 
often in the prime of their life, the ensuing distress could well be imagined. Even if the 
bitten person who escapes death, might be left with permanent disfigurement or a 
crippling handicapped or long term or belated complications which will tell on the 
quality of life and the unusefulness to himself and to his family. It is likely that for 
every snake bite death, several survivors are left with chronic disability including 
physical handicap from necrotic effects of the venom requiring amputation, chronic 
ulceration, osteomyelitis with malignant transformation , chronic renal failure, chronic 
pituitary adrenal insufficiency and neurological sequelae from intracranial 
hemorrhages and thrombosis. 
 
 
15 
 
According to Vaiyapuri‘s survey, almost 13-14% of children of 0-10 years in 
all the three villages Erode district of Tamil Nadu, suffered snakebites. The numbers 
increased to almost 19% in the age group between 11-20 years. Further there is no 
appropriate data on snakebite victims and there is no proper reporting system. We 
need to generate these and make them available for researchers. In a study at West 
Bengal only 22.19% of snake bite cases reported to the government hospitals whereas 
the rest of the patients were dependent on the local traditional faith healers
 [8]
. 
A substantial number of these deaths and long lasting complications of long 
disabilities could be avoided by some knowledge of precautions against snake bite and 
the proper mode of treatment. Even though snake bite has been reviewed with greatest 
dread from the time, our earliest ancestors, prayers, incantations, rituals, charms, use 
of ―snakestones‖, countless bizarre concoctions, herbal preparations, many quick-fix 
techniques, all have been tried from the beginning, only to be discredited sooner or 
later. Modern medicine has fared only a little better. Whether in the recommended 
practices in first aid or in the use of antivenin, there have been so many ambiguities 
and uncertainties and even contradictions. Many of the practices once adopted by 
medical practitioners in first aid and some recommended even in recent decades are 
now considered useless or even harmful. In administering antivenin, there are so many 
precautions to be observed that even experienced medical practitioners have to be 
aware of what they are doing. And there could be side effects which have serious 
implications. There are issues on which the jury is still out. 
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THE BIG FOUR 
The description of ―THE BIG FOUR‖ is for the benefit of the layperson and 
the physicians who should know enough of the snakes- that is these four kinds (Cobra, 
Common Krait, Russell‘s viper, Saw scaled viper) – which together account for the 
bulk of fatalities and life-threatening consequences of snakebite in India. The 
argument is also heard that the usage of the term ―Big four‖ has lulled laboratories and 
manufacturing facilities into the belief that they need not consider antivenin for other 
life-threatening species. The reason that they have gone beyond the ―Big Four‖ is that 
in view of the rarity of bites from the other species (Hypnale hypnale, Echis sochureki 
& king cobra) and the very high cost of manufacture of antivenin, it is just not 
commercially viable to take them up. The concept of the ―Big 4‖ snakes is reviewed to 
demonstrate its failure to include all currently known snakes of medical significance 
in India and its negative effects related to clinical management of snakebite. Most of 
the reports from the regions of south India have a higher incidence of reporting snake 
bite due to  Hump nosed pit viper (Hypnale hypnale) has reduced the concept of ―Big 
4‖. The ―Big 4‖ concept is controlling sound epidemiology and the development of 
effective ASV. It should be replaced by the model, introduced in the 1980s by the 
World Health Organization, which has not received adequate circulation and 
implementation
 [9]
. 
Russell‟s viper (Daboia russelii) 
The Russell‘s Viper is a stout bodied snake, the largest of which grows to 
approximately 1.8 meters in length. Like all the vipers it is a nocturnal snake, but 
unfortunately for humans, during the daytime it rests up under bushes, at the base of 
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trees and in leaf litter. It is therefore frequently encountered by rural workers as they 
are carrying out general agricultural activities. It yields 21-268mg of venom
[10]
.  There 
are two key identification features that are worth noting. The first is a series of chain-
like or black edged almond shaped marks along the snakes back and flanks. The 
second distinguishing mark is a white triangular mark on the head with the apex of the 
triangle pointing towards the nostrils. 
Saw scaled Viper (Echis carinatus) 
             The southern indian Saw Scaled Viper is a small snake, usually between 30 
and 40 centimeters long. The northern Indian species (Echis sochureki) is much larger, 
with an average size of 60 centimeters. It yields 18 to 72mg of venom. It inhabits 
mainly dry arid climates but can also be found in scrubland. One of the key 
identification features of this species is the posture it adopts when it is agitated. It 
moves its body into a figure of 8 like arrangement with its head at the center. It rapidly 
moves its coils against each other and produces a hissing like sound which gives its 
name of ‗Saw Scaled‘. In addition, there are often wavy hoop like markings down 
both sides of the Saw Scales body. On the head, there is usually a white or cream 
arrow shaped mark, pointing towards the front of the head, often compared to the 
shape of a bird‘s foot. 
Spectacled Cobra (Naja naja) 
           The Spectacled Cobra is probably India‘s most well recognized snake. 
The hood markings of the spectacle like mark, distinguishes this snake from other 
species and its habit of rearing up when alarmed makes it distinctive but not definitive 
as other species do this, notably the Trinket Snake. In vitro studies have found that the 
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species from eastern part of India is neurotoxic and procoagulant. Whereas the 
western species are myotoxic and anticoagulant
[12]
. They yield venom ranging from 58 
– 742mg[13].  The Cobras coloration may vary from pale yellow to black. One of the 
studies in Chennai has evolved a cocktail antiserum against this species using 
monoclonal antibodies for the management of snake bite treatment in future
[14]
. 
Common Krait (Bungarus caeruleus) 
             The Common Krait is a nocturnal snake which usually grows to 
approximately 1.0 to 1.2 meters in length. Its primary diet is mostly snakes and 
rodents. It can be found all over Peninsular India and often seeks habitation near 
human dwellings. During the day it rests up in piles of bricks, rat burrows or other 
buildings. It can produce 8-60mg of venom
[15]
. The Common Krait is the most 
poisonous snake in India and its venom is pre-synaptic neurotoxic in nature. There are 
a number of key identifiers which are worth remembering. The Krait is black, 
sometimes with a bluish tinge, with a white belly. Its markings consist of paired white 
bands which may be less distinct anteriorly. These paired white bands distinguish the 
snake from another black nocturnal snake, the Common Wolf Snake. The Wolf 
Snake‘s white bands usually are thicker and are singular bands equidistant from each 
other. The second useful distinguishing feature is a series of hexagonal scales along 
the top of the snakes back. This feature is really useful if the dead/alive snake has 
been brought to the hospital and examined. 
The Hump-nosed Pit viper (Hypnale hypnale) 
The Hump-nosed pit viper is one of India‘s tiniest venomous snakes, its total 
length ranging from 28.5 to 55cm. Its distinctive features include the presence of five 
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large symmetrical plate scales on the top of the head in addition to the smaller scales 
typical of all vipers. There are heat sensitive pits between the nostril and the eye. 
Mostly, this species is frequently mistaken as saw-scaled vipers (E.Carinatus) in 
Kerala
[11]
. 
King cobra (ophiophagus hannah) 
 One of the largest venomous snakes in Western Ghats. It occurs wherever 
relatively undisturbed bamboo stands and forests remain, but have not caused 
documented bites in recent years. One of the very first reports on Indian king cobra 
venom was not neutralized by the commercially available polyvalent ASV and so 
there is no antivenom therapeutically and commercially available in the Indian 
subcontinent to treat king cobra bite
[16]
. The production of antivenom for king cobra is 
still to be considered. 
Table 1: The Honors of `The Most Dangerous‟ Have To Be Shared By 4 Snakes: 
The most widespread in distribution  
The Indian cobra i.e. the spectacled cobra 
and monocled cobra taken  together (Naja 
naja and N.kaouthia) 
The commonest within its range  
Occurrence in areas with the densest 
Human population  
Frequency exposure to humans 
Potency of venom The common krait (Bungarus caeruleus) 
Frequency of bites The Russell‘s viper (Daboia russelii) 
Frequency of fatal or life-threatening 
envenomation by bites  
The saw scaled viper (Echis carinatus) 
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Table 2: Clinical Aspects and Therapeutic Response of The Most Commonly 
Available Snakes In India: 
FEATURE COBRAS  KRAITS  
RUSSELLS 
VIPER 
SAW 
SCALED 
VIPER 
HUMP 
NOSED 
VIPER 
Local Pain / Tissue 
Damage 
YES  NO  YES  YES  YES 
Ptosis / 
Neurological 
Signs 
YES  YES  YES  NO  NO 
Haemostatic 
abnormalities 
NO  NO!  YES  YES  YES 
Renal 
complications 
NO  NO  YES  NO  YES 
Response to  
neostigmine 
YES  NO  NO 
NOT 
applicable 
NOT 
applicable 
Response to ASV YES  YES YES YES NO 
There is no antivenin manufactured in India for king cobra bites. A monovalent 
antivenin for its bite is manufactures in Thailand and a polyvalent one in china. But, 
considering the variations in geographical races, it remains to be seen how far they are 
effective for the bite of a king cobra in India. In the meantime we may draw some 
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comfort from the fact that in the last over 20 years, only four deaths from king cobra 
bite have been reported from India, all from south India. 
THE SNAKE VENOM 
The venom in the snake is secreted in two glands which are modifications of 
the parotid or salivary glands that occur in other vertebrates. These glands are located 
on the snake‘s mouth which is below and behind the eye. The venom can be described 
as `modified saliva‘. Its purpose is firstly to immobilize or kill the prey before it is 
swallowed and secondly to aid digestion by breaking down the prey‘s tissues. The 
venom of each species is unique with a different composition of toxic and non-toxic 
constituents. Venoms are 90% proteins and these are mostly enzymes and about 25 
such enzymes have been isolated, the matter of which may differ according to species. 
Some of the toxic components in the venom are not enzymes. The enzymes and other 
components have different destructive properties, namely: 
 Cytotoxins damage the tissues. 
 Haemotoxins cause heavy bleeding internally and externally. 
 Neurotoxins impair the nervous system. 
 Cardiotoxins act directly on the heart. 
 Myotoxins damage the muscles. 
Various toxins in snake venoms exhibit a high degree of specificity toward 
cholinergic receptors. The α-neurotoxins from the Elapidae family interact with the 
agonist-binding site on the nicotinic receptor. Alpha-Bungarotoxin is selective for the 
muscle receptor and interacts with only certain neuronal receptors such as those 
containing α 7 through α 9 subunits.   Neuronal bungarotoxin shows a wider range of 
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inhibition of neuronal receptors. A second group of toxins called the Fasciculins 
which inhibits AChE. A third group of toxins, termed the muscarinic toxins (MT1 
through MT4) includes partial agonists and antagonists for the muscarinic receptors. 
Venoms from the Viperidae family of snakes and the fish-hunting cone snails also 
have relatively selective toxins for nicotinic receptors. The actual distribution of 
AChE in various snake venoms is poorly known due to the limited number of 
published accounts. However, snake venoms are the richest source of AChE known 
and contain only the soluble globular form of AChE.  
Approximately there are 2,500 different species of snakes. About 20% are 
venomous and these are divided into numerous subfamilies of the families Elapidae 
and Viperidae and the polyphyletic family Colubridae. Among these, the Elapidae is 
the main subfamily that possesses significant AChE activity. The Crotalinae and 
Viperinae subfamilies lack this enzyme, and the presence of AChE is unknown in the 
Hydrophinae. In the Elapidae, all venoms assayed contain AChE except those from 
the genus Dendroaspis (Mambas). In Dendroaspis, instead of AChE, venoms contain 
very potent reversible inhibitors of AChE, the Fasciculins which bind at the peripheral 
site of the enzyme. Venom of the coral snakes (Micrurus) is also a rich source of 
AChE. The catalytic characterization of affinity-purified AChEs from the venoms of 
four elapid genera showed that they share features of other vertebrate AChEs such as 
inhibition by eserine, preferential hydrolysis of acetyl rather than of propionyl or 
butyryl esters and substrate inhibition
[17]
. 
 Snake venoms can be classified as haemotoxic i.e. attacking tissue and blood 
(Russell‘s viper and saw-scaled viper) and neurotoxic i.e. damaging or destroying 
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nerve tissue (cobras and kraits). Exceptionally viper venom can cause some 
neurotoxic effects also. A curious feature of the venom is that its composition not only 
differs from species to species, as mentioned above but may differ even among 
individuals of the same species representing different geographical races and 
surprisingly even among individuals of the same litter. Paradoxically enough, the 
new-born and the very young have more potent venom than adults.  
Table 3: Fatal Dose, Venom per Bite and Average Time Between Bite and Death 
SNAKE SPECIES FATAL 
DOSE 
VENOM PER 
BITE 
AVERAGE TIME BETWEEN 
BITE AND DEATH 
Naja naja (Cobra) 15mg 200-350mg 8 hours (12 minute2 to 120 
minutes) 
B caeruleus 
(Krait) 
40mg 150-200mg 18 hours (3 to 63 hours) 
Daboia russelli 
(Russell‟s viper) 
  
6mg 22mg 3 days (5 minutes to264 hours) 
Echis carinatus 
(Saw scaled viper)
  
8mg 4.5mg 5 days (25 hours to 41 days) 
 
Neutralizing capacity of 10 vials of ASV in India (100 ml) for:   
i) for Naja naja (Cobra) – 60mg,    ii) B caeruleus (Krait) - 45 mg,     
iii) Russell‘s viper 63 mg - 60 mg,   iv) Saw-scaled viper 45 mg [18]. 
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SPECIAL FEATURES OF SNAKE BITE 
i. Male snakes produce more venom than females.   
ii. There may be seasonal variations in the quantum and potency of the venom 
produced. 
iii. The venom is more toxic immediately after the snake moults. Conversely, if it 
is nearing its moult, the venom will be less toxic. 
iv. The quantity of the venom in the glands is likely to be less if the snake had a 
prey recently. When the venom glands are completely emptied by forceful 
venom extraction, it requires around 2 weeks to regenerate the venom
 [19]
. 
v. Experiments have shown that the snakes can voluntarily control the quantity of 
venom injected. If the intention of the snake is only to frighten a perceived 
enemy, it may inflict a bite without injecting any venom – the `dry bite‘- or the 
venom discharged may be minimal. 
FACTORS AFFECTING THE SEVERITY OF SNAKE BITE 
i. The mental state and behavior of the victim. If the victim is agitated or runs or 
exerts him after the bite, it will speed up the action of the heart and lead to 
faster absorption of the venom in the blood. 
ii. Excessive movement of the bitten limb will lead to greater absorption of the 
venom. 
iii. Whether the bite was on a bare body part or through clothing. 
iv. The number of bites influences the quantity of the venom injected. 
v. Presence of micro-organisms in its mouth, these may enter the wound and 
aggravate the problem. 
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vi. Adverse effect of wrong procedures followed in first aid results in damage to 
the tissues or lacerations leading to greater absorption of the venom. 
vii. The extent of the delay in getting expert medical attention. 
TRADITIONAL CURES & MYTHS OF SNAKEBITE 
• Biting off the head of the snake that has bitten or biting hard on its body. 
• Body parts of venomous snake, such as the head, heart, liver etc., preferably of 
the culprit, processed in various forms and consumed or applied to the bite site. The 
belief is as old as Aristotle (384-322 BC). In his history of animals, he was categorical 
that the body of the species was the only known remedy for its bite. 
• A mixture of mercury and snake venom evaporated and applied to the bite site. 
• Poultices of goat‘s cheese applied to the bite site. 
• The bitten limb immersed in goat‘s milk. 
• Pig‘s lard, rancid butter or olive oil applied to the bite site. 
• Bleeding flesh of live chicken applied to the bite site in the belief that it will 
suck out the venom. 
• Animal excreta applied to the bite site. 
• Human urine applied to bite site. 
• Bowels of a snake applied to the bite site. 
As regards the `snakestone‘, the belief is that when it is placed on the bite site, 
it adheres to the wound, sucks out the poison and then falls off. If it is then immersed 
in milk, the poison will drain out and the stone can be dried and re-used. His belief has 
been widespread in India at least till recent times. Jean-Philippe chippaux says that it 
has existed even in European countries but had travelled there from India around 1650 
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and had found mention in 1656 document popularizing far eastern customs. The 
belief, in all probability, occurs in other countries as well. Many different substances 
have been identified as `snakestones‘: burnt bones, pumice, porous chalk, calcined 
antlers of sambar and bezoars found sometimes in the stomach of certain ruminants 
like cow, buffalo, sheep, etc., and other animals. 
The following account of the various methods will be of interest: 
Tourniquet:  
It has long been the best-known first aid for snakebite and even today, this is 
the first thing that occurs to most people when first aid for snakebite is mentioned. It 
was mentioned as long back as the 2
nd
 century A.D. by the Greek physician, Galen, 
and has been highly recommended by many different authorities including well-
known physician‘s right down to recent times. It consists of a strip of cloth or rubber 
band tied tightly above the bite site to prevent or retard the venom travelling up the 
circulating system. Over a period of time it was realized that a very tight tourniquet 
was not necessary since the venom travels through the lymphatic system and the vein 
which lie just below the surface. Further, if the tourniquet completely chokes the 
arteries, the denial of all blood supply to the tissues will lead to gangrene which may 
be irreversible, leading to amputation of the limb. It was, then, recommended that the 
tourniquet should not be very tight and should be loose enough to allow the insertion 
of one finger under it. It was further recommended that it should be loosened once in 
30 minutes and then tightened again. This is a dangerous procedure since the venom 
that had collected below the tight tourniquet will then surge into the lymphatics and 
the blood stream. It is now established that the tourniquet will do more harm than 
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good and should not be used. It should also be noted that the tourniquet gives the 
victim and his caretakers a false sense of security and this will further encourage the 
delay in reaching a hospital. The effectiveness of the tourniquets among Russell's 
viper bite victims in retarding venom movement from the bite was studied in 37 cases 
by measuring venom antigen levels by ELISA in venous samples taken proximal and 
distal to the tourniquets and also before and after release of tourniquets. In most cases, 
the tourniquet did not prevent proximal spread of venom. In 8 of 37 cases, the venom 
antigen assays did not prove the delayed absorption by using tourniquet
 [20]
. 
Application of substances to bite site: 
 The traditional remedies mostly fall in this area and have no effect on venom. 
One such remedy which can be described as `modern‘ is the application of a chemical 
known as ethylene diamine tetra acetic acid (EDTA). To be effective it must be 
injected quite promptly after the bite. It does not counteract the lethal effect of the 
venom. 
Application of potassium permanganate: 
 Also referred to as Condy‘s crystals, used to be recommended to be rubbed into 
the bite site or applied as a solution in the belief that it destroyed the toxin by 
oxidizing it. This is said to have been introduced in 1881 by De lacerda and has been 
popular till recent times. Further, it interferes with the lymph flow from the wound 
which normally would remove some venom. Rubbing the crystals on the wound may 
add to the complications. 
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Cauterization: 
 This refers to burning the flesh around the bite site by application of a red-hot 
iron or fire or acid or scalding oil. This is a dangerous procedure that will have no 
effect on the venom but will damage the tissues irretrievably. 
Slashing the bite site with a knife or razor blade: 
 This is done in the belief that the venom will ooze out along with the increased 
flow of blood. But it does not, since the venom goes into the system very quickly and 
no significant portion may be left at the bite site to be drained off in this fashion. 
Further, there is every danger of grave injury to nerves, tendons and blood vessels and 
also the risk of infection. 
Amputation of the bitten limb: 
 This will not work as a first aid measure since by the time this is accomplished; 
the venom might have travelled well up into the systemic circulation. It may also, later 
on, be found to have been unnecessary if there was really no serious envenomation. 
Suction of the wound by mouth: 
 This is used to be widely recommended till recent times. This does not work if 
the venom has already been absorbed into the system which happens fairly rapidly 
after a bite. Experiments in the U.S. have shown that suction started after three 
minutes removes only less than one-thousandth of the venom. Further, the procedure 
may infect the wound. These apart, it is very risky for the aid-giver if he has any 
abrasions or sores in the mouth or lips or cavities in the teeth, which he may not be 
aware of himself , in which case it will be in the individual to get envenomed. 
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Suction of the wound by devices: 
 Suction devices such as sawyer extractor have been in use especially in the 
West. These too generally have no effect since, as already mentioned, the venom gets 
absorbed into the systemic circulation within minutes. When it is used within 5 to 15 
minutes, appreciable amount of venom can be removed. In Indian conditions, 
therefore, use of a mechanical extractor effectively is hardly feasible. There is also a 
view that use of a suction device may increase envenomation as it inhibits natural 
oozing of venom from the bite site and may also promote necrosis or cause excessive 
bleeding especially in viper bites where the blood loses its ability to coagulate. 
Cryotherapy or Cryopathy: 
 This involves application of icepacks or cold compresses to the bite site and it 
was highly recommended for a long time in U.S. for rattle snakebite. Its chief 
proponent was Herbert L.Stalinka of Arizona State University. Cryotherapy now 
stands discredited. It is not only effective but will also damage the tissues, causing 
necrosis. 
Electroshock therapy: 
 Applying electric shock to the wound site with an insulted rod used to be done 
for rattler bites in America and was popular in the 1980s. The belief was that this 
denatured the venom. This treatment is useless and dangerous. It may cause serious 
burn at site or may even injure the heart. 
Consumption of alcohol: 
 This used to be popular remedy especially for rattle snakebites in the U.S. 
during the prohibition days. L.M. Klauber, a leading herpetologist, is credited with the 
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statement: ―The rattler, more than any other cause, made the high plains country a 
hard-liquor area‖. Alcohol is, in fact, contra-indicated. It dialates the blood vessels and 
speeds up the blood circulation leading to faster absorption of the venom. 
The following account of the various guidelines by WHO: 
Local compression pad or `Monash technique‟: 
 The 1998/2005 guidelines of WHO : ―The use of a local compression pad [a 
hard pad of rubber or cloth] applied over the wound, without pressure bandaging of 
the entire limb, has produced promising results in Myanmar and deserves further 
study‖. The recommendation of S Grenard (1994) on the application of small (4``x4``) 
wad of folded (to 1``x 1`‘ size) gauze dressing strapped tightly over the fangs marks. 
It is stated that this may delay the spread of the venom while limiting the area of 
possible tissue damage consequent on being restricted to a small area. This method 
needs further study. 
The `Sutherland technique‟ or Pressure immobilization Method: 
  Guidelines for management of snake bite (2016) by WHO includes Sutherland 
technique recommended by Dr.Struan K. Sutherland (1936 -2002) in 1981 had two 
components. One is the application of a pressure bandage to impede the flow of lymph 
and venous  blood, thus preventing or slowing down of the systemic absorption of the 
venom and at the same time, not interfering with the flow of blood through the arteries 
to the tissues. A roll of crepe bandage about 10 cm wide and 4.5 m long, is ideal for 
this. Bandaging should be over the bitten area first and then extended from the toes or 
hands upwards. The other component is the immobilization of the limb through resort 
to a splint loosely but firmly tied to the limb with strings and if the bite is on upper 
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limb, the limb cradled in a sling tied to the shoulder as in the case of a fracture to the 
limb. The immobilization of the limb will impede the pumping action of the skeletal 
muscles, thus slowing down the passage of the venom. The objection is that, to be 
effective, the pressure applied has to be very precise and this varies between the upper 
and lower limbs. The pressure on the upper limb has to be 40 – 70 mmHg and on the 
lower limb 55- 70 mmHg. If the victim walked, 10 minutes after application would be 
ineffective. It has been pointed out that even doctors are not able to judge the specific 
pressure to be applied correctly and therefore this is near impossible in the field. 
Further to be effective, the pressure bandage has to be applied within a few minutes of 
the bite and this is not feasible in the field conditions in India.  
Immobilization of the limb: 
This part of the pressure immobilization method has to be considered as a first aid 
measure by itself and is desirable. Tying a splint to the limb and supporting it in a 
sling, will slow down the progress of the venom by preventing the pumping action of 
the skeletal muscles. 
 But most parts of India, majority of people still follow the crude methods as 
first aid measures which will delay the vital time complicate the treatments. 
ANTIVENIN 
The only scientifically proven antidote to snake venom is anti venene, now 
generally spelt as `antivenin‘, also called anti snake venom (ASV) or antivenom 
immunoglobulin. Injected intravenously into the body, this neutralizes the venom. It 
was in 1887 that Henry Sewell of the University of Michigan, USA, conducted 
experiments on snake venoms and laid the foundations for antitoxin therapy. In 1891, 
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Calmette followed up the research works and discovered antivenin. (Calmette‘s name 
is immortalized in BCG – Bacillus Calmette-Guerin – used in the inoculation against 
tuberculosis). He discovered this vaccine jointly with Camille-Guerin. Albert 
Calmette a French scientist of Pasteur institute working at its Indochine branch in 
1895 developed the first antivenom for snakes (called an anti-ophidic serum) against 
the Indian Cobra (Naja naja). Fraser in Edinburgh coined the term `anti venene‘, now 
spelt as `antivenin‘. Antivenin first became available on commercial scale in 1927 – in 
the United States. In India, antivenom production began at the Central Research 
Institute, Kasauli, Himachal pradesh during the 1920s. 
 Parentral administration of antivenom is the only specific antidote to snake 
venom and the cornerstone in management of snake bites
[21]
. Antivenoms are derived 
from immunoglobulins, obtained and purified from the plasma of animals immunized 
with snake venoms. Selection of snake venoms is critical to cover the majority of 
cases of envenoming in a particular given geographical region. The composition of 
snake venom is complex and a high inter/intra-species variation has been documented. 
Production of antigenic mixture to be used for antivenom production is a challenging 
task for manufacturers
[22]
. 
Monospecific antivenoms 
They are used clinically for effective cross neutralization of single or closely 
related snake species envenoming. It is practically possible only when there is a very 
high prevalence of a single species of snakes in the desired region, but most of the 
countries are inhabited by more than one medically relevant species of snakes, where 
the use of polyspecific antivenoms is highly recommended. 
 
 
33 
 
Polyspecific antivenoms 
 The polyspecific antivenoms are obtained by immunizing an animal (preferably 
horse) with venoms of more than one species of snakes of high medical relevance to 
the concerned geographic area/region. Another methods of production includes 
i)immunizing individual animals with venom of a single species and then mixing the 
various hyper immune plasmas for fractionation and ii) mixing appropriate quantities 
of relevant purified antivenoms before formulation. These polyspecific antivenoms 
should be promoted whenever feasible, as they offer clinical advantages like better 
usefulness than monospecific antivenoms. Their use reduces the need for 
identification of snakes, prior to initiation of antivenom therapy and simplicity in 
logistics provides great advantages. 
The basic procedure in manufacture of antivenin is as follows: 
 At the first stage, venom is extracted from the snake by making it bite   on   an  
s-rubber plastic diaphragm stretched and tied over a glass receptacle. The venom 
which will have saliva and other impurities is purified by centrifuging and it is 
preserved at -10°C. It is freeze-dried using a lypophilizer and reduced to a powder 
form and stored in airtight bottles. Its shelf life in this form can be as much as 12 
years. At the second stage, the venom is reconstituted as liquid and a very small 
quantity is injected into a horse. Repeated injections are given at periodic intervals and 
the dosage being increased gradually. The horse‘s immune system produces anti-
bodies in its blood to fight the venom. At a certain stage, the horse‘s blood is extracted 
and the blood serum which contains the antibodies is separated and purified. This is 
the antivenin. The final product marketed is in crystal form. As and when necessary, 
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this will be reconstituted in hospitals with distilled water in prescribed proportions and 
used for injecting the victim of snakebite intravenously. Nowadays, plasmapheresis, 
whereby erythrocytes are re-injected into the donor animal within 24 hours of blood 
collection, is commonly employed to reduce anaemia in the hyperimmunized animal 
that donates the plasma. Accordingly, it is almost exclusively, plasma rather than 
serum that is used as the starting material for the extraction of the immunoglobulin or 
its fragments. 
 The venom of the cobra/krait and the viper has different characteristics. 
Therefore, to get the best results, the antivenin has to be prepared specifically for 
cobra or krait or viper. This is called monovalent antivenin. But this gives rise to some 
practical problems. Most of the victims and the doctor cannot be certain about the 
snake that has bitten especially when it happens during the night or among people who 
are not well-informed. The use of monovalent antivenin without being sure about the 
snake species can have dangerous consequences. Therefore, a polyvalent antivenin is 
manufactured by injecting the horse with a mix of the venoms of different species of 
snakes. But a polyvalent antivenin has its own drawbacks. It is not as effective as 
monovalent antivenin, thus necessitating larger dosages which results in pushing up 
the cost of treatment, the antivenin being a very costly drug. It may also cause more 
adverse side-effects compared to monovalent antivenin. 
 Currently the laboratories in India produce only a polyvalent antivenin which is 
used for the bites of the different species of cobras and kraits and pitless vipers found 
in India. It is not effective against the bites of the king cobra or the pit vipers or sea 
snakes. Even among the same species of snakes, there are variations in the 
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compositions and potency of venom produced by individuals in different geographical 
areas. This places limitations on the efficacy of the antivenin produced in a particular 
facility using venom from snakes in a particular area. This limitation can be there even 
within the same country. For severe cases of envenomation, the maximum dosage 
required will be 20 vials in the case of neurotoxic bites (cobra, kraits) and 30 vials in 
the case of haemotoxic bites (Russell‘s viper, saw-scaled viper). Neurotoxic snake bite 
is an independent predictor of mortality in snake bite patients. Currently used 
polyvalent ASV may be less effective in treating neurotoxic snake bite
[23]
. 
 The Irula Snake Catchers Industrial Cooperative Society (ISCICS), Madras 
Crocodile Bank on Chennai‘s East Coast Road which operates in two districts of 
Tamil Nadu totaling 7,850 sq. km, is a tribal self-help project set up in 1978. They 
also conquer the traditional knowledge of medicinal plants for the management of 
snake bite
[24]
. The Madras Crocodile Bank Trust and Centre for Herpetology (MCBT), 
in association with experts at the Indian Institute of Science (IIS), Ashoka Trust for 
Research in Ecology and the Environment (ATREE),Vellore Institute of Technology 
(VIT), the Australian Venom Research Unit (AVRU) from the University of 
Melbourne and the Global Snakebite Initiative have begun an ambitious project 
working with government and antivenom manufacturers to revolutionize the 
Production of snake antivenoms for use in India. 80 percent of the venom currently 
used to raise indian polyvalent venoms is collected by the irula cooperative for snakes 
inhabiting in one small area around Mahabalipuram in Tamil nadu The Society is 
licensed by the Tamil Nadu Forest Department to capture an average of 8,000 snakes 
per year of the four most medically important species, the ‗big four‘. Snakes are kept 
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in captivity for 3–4 weeks and venom extracted four times from each snake. Snakes 
are then released back to the wild. The state forest department license determines the 
number of snakes permitted to be caught and the relative quantities of venom 
produced. This has resulted in a perennial surfeit of cobra and Russell‘s viper venom, 
hence the Irula Cooperative stipulates that buyers must purchase venom in a ratio of 5 
: 5 : 1 : 1 (Naja : Daboia : Bungarus : Echis). For buyers who wish to purchase only 
krait or saw-scaled viper venom, the price is an astronomical US$ 3888 per gram13. 
In the year 2010, the Antivenom producers have expressed concern over the high 
venom prices and the purchase of Venom from the Irula Cooperative venoms dropped 
down considerably. New methods of immunization require much less venom to 
produce the same results which will of course reduce demand even further. 
Comparing the cost for Indian snake venoms produced in the USA are 600 US$ for 
Russell‘s viper, 150 US$ per gram for spectacled cobra, and 400 US$ for saw-scaled 
viper (Kentucky Reptile Zoo). The Irula Cooperative now produces a major portion 
(an estimated 80%) of India‘s venom needs (for the production of antivenom) from 
snakes found within two districts of Tamil Nadu. They charge (as of April,2008) 
Rs.10,000 per gram of cobra and Russell‘s viper venom and Rs.30,000 to Rs.80,000 
per gram of saw scaled viper and common krait venoms. Therefore, it would be 
advantageous to expand the scope of the cooperative activities to other parts of the 
country by becoming a multi-state cooperative in order to include other snake catching 
communities under its wing. This will possibly benefit the snake catchers and also 
effectiveness of the regional venom variation improves which possibly makes the 
others snake species medically important. However, it is to be noted that the standards 
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of venom production and protocols of the cooperative have considerable scope for 
improvement in conformity with WHO guidelines
[25]
. Clinicians in other parts of the 
country are reporting that the antivenom they are using is relatively ineffective in 
counteracting the effects of a venomous bite. In Rajasthan, envenoming by subspecies 
in saw-scaled viper (Echis carinatus sochureki) requires larger doses of antivenom 
than smaller subspecies (E.c.carinatus) in the South.  So, there is geographic variation 
in the composition of the venom of a single species. In the year 2016-17 the 
geographical survey of India (GSI) and the MCBT hope to raise US$20,000 to make it 
possible to complete the testing of venom from representative Indian Russell‘s viper 
populations spread right across India.  
ANTIVENIN IN INDIA 
 Only polyvalent anti-venom is produced in India. It contains F(ab)2 
antibody and its half-life is approximately 80-100 hours. The ASV preparation in 
India is available in two forms  
 LYOPHILISED LIQUID 
ADVANTAGES Long Shelf Life (5 Years) 
Requires no cold chain 
Speed of reconstitution 
immediate 
DISADVANTAGES Speed of reconstitution of 
30-60 minutes 
Short Shelf Life (2 years) 
Requires a cold chain 
 
The cold chain is a useful feature in remote areas where power supply is 
inconsistent. The advantage of the lyophilized form is that it does not require 
refrigeration. However, it is more expensive than the liquid preparation. Ways and 
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means should be explored to drastically bring down the cost of antivenin. The cost of 
treatment with antivenin today is prohibitive. An average dose of antivenin will be 
about 10 vials (of 10ml each). A patient will ordinarily need about 10 vials and this 
may go up to 20 to 30 vials in very bad cases. One vial of 10 ml. costs Rs.400 to 
Rs.450 (as of July 2008). The ministries of health supply ASV free of cost but their 
supply remains insufficient and irregular which has led a lot of patients to purchase in 
case of private hospital
[26]
. One way to bring down the cost is by switching over to 
monovalent antivenins as mentioned above. The other is by using alternative media 
for production of antivenin instead of relying exclusively on horse serum. Some work 
has been done in other countries for the production of antivenin from sheep serum and 
from egg-yolk but no such work has been done in India. Recently camelid IgG 
monospecific antivenom was studied to be efficacious and a better choice in snake 
specific envenoming
[27]
. A study in Pakistan states that indian antivenoms 
significantly neutralized the pro and anticoagulant activity of Pakistan Russell‘s viper 
venom
[28]
. Several polyvalent ASV manufacturers have been established, all of which 
follow the Indian pharmacopoeia requiring products which neutralizes 0.6mg/ml of 
Naja naja venom, 0.6mg/ml of Daboia russelli venom, 0.45mg/ml of Bungarus 
caeruleus venom and 0.45mg/ml of Echis carinatus venom. Since the early 1950s the 
potency of ASV has much reduced where earlier indian ASV neutralize 4mg/ml 
Daboia russelli venom and 2mg/Naja naja venom was used
[29]
. 
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Table 4: MANUFACTURERS OF ANTISNAKE VENOM IN INDIA 
PUBLIC SECTOR PRIVATE SECTOR 
 Central Research Institute Kasauli. 
(Reduced Production) 
 Haffkine Biopharmaceutical 
Company Ltd. Mumbai. 
(Production 2015-2016: 40, 00,000 
vials) supplying Maharashtra 
 Bengal chemicals & 
pharmaceuticals, Calcutta. 
(Currently stopped Production) 
 King‘s Institute of Preventive 
Medicine, Madras. 
(in 2016 announced resumption of 
production after a 15 year break) 
 
 Serum Institute of India, Pune  
(Reduced Production) 
 VINS Byproduct Ltd., Hyderabad. 
(Production 2015-16: 10, 00,000 
vials) 
 Biological E.(Evans) Ltd., 
Hyderabad. 
(Production 2015-16: 5, 00,000 
vials of liquid antivenom only) 
 Bharat Serum and Vaccines Ltd., 
Mumbai. 
(Production 2015-16: 80,000) 
 Mediclone Biotech Pvt. Ltd, 
Chennai 
(Production 2015-16: 40 000 vials, 
reducing production) 
 Premium Serum and Vaccines, 
Mumbai 
     (Production 2015-16: 6, 00,000   vials) 
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PHARMACOLOGY OF ANTI SNAKE VENOM 
 The pharmacology of various types of antivenom differs due to the difference 
in their molecular masses. It is expected to be similar to other intravenous drugs 
being delivered to the central compartment with zero order input kinetics (constant 
rate of infusion). Antivenom is then distributed throughout the body and is eliminated 
by the kidneys and/or the reticuloendothelial system.  
DISTRIBUTION  
A) Volume of Distribution  
1) The composition of antivenom can vary depending on the degree of purification 
and the degree of antibody fragments [IgG, Fa(ab')
2 
or F(ab)]. In general, venom 
distributes mainly into the tissue compartments, while IgG and F(ab'
)2
 distribute only 
weakly out of the plasma volume; therefore they are unable to neutralize antigens 
within the tissue. 
2) F(ab')
2
 fragments - volume of distribution is approximately twice as high as plasma 
volume, which suggests a poor distribution in tissue. The fragments however 
distribute more rapidly than whole IgG.  
B) Peak Plasma Level  
1) IgG - the concentration peak is reached in 6 hours in superficial tissue and 30 hours 
for deep tissue. 
2) F(ab')
2
 fragments reach a concentration peak in 1 hour in superficial tissue and 6 
hours in deep tissue  
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EXCRETION  
1. Kidney  
F(ab) is excreted via the kidneys. This is only possible when F(ab) is free or 
combined with a hapten and not when it‘s combined with venom proteins. A potential 
risk of renal lesions due to F(ab) immune complexes has been observed in some 
patients, as noted by a significant decrease in the rate of Creatinine clearance. 
2. Other  
IgG and F (ab')
2
 are excreted via cells of the immune system. Glomerular 
filtration stops for molecules that are higher than 50 to 60 kDa. 
 Rapid elimination of some therapeutic antivenoms (e.g. when Fab fragments 
are used) has led to recurrence of envenoming in patients. However, the choice of 
preparing specific IgG or fragments appears to depend on the size and toxicokinetics 
of the principal toxin(s) of the venoms. Large relative molecular mass (Mr) bivalent 
antibodies (IgG and F(ab')
2
 fragments) may be effective for the complete and 
prolonged neutralization of intravascular toxins (e.g. procoagulant enzymes) which 
have a long half-life in envenomed patients, whereas low Mr and monovalent IgG 
fragments such as Fab may be more appropriate against low-molecular-mass 
neurotoxins which are rapidly distributed to their tissue targets and are rapidly 
eliminated from the patient‘s body [30].  
 One ml. of polyvalent antivenin neutralizes 0.6 mg of cobra and Russell‘s viper 
venom and 0.45 mg of krait and saw-scaled viper venom. Antivenin is marketed in 
vials of 10 ml each (liquid) or equivalent in lypophilized form. Liquid antivenin is 
very unstable at room temperature. It requires storage at 0°C to 4°C and even then its 
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shelf life is only two years, lypophilized antivenin has a shelf life of five years when 
stored in a cool dark place. Preferably, it should be stored in a refrigerator 
To retain their full potency within the limits of stated expiry dates, lyophilized 
antivenoms (shelf life about 5 years) should be stored at below 25ºC and liquid 
antivenoms (shelf life 2-3 years) should be stored at 2-8 ºC and not frozen. The 
antivenoms should be used within the stated expiry dates with proper storage. Studies 
report that, they can also be expected to retain useful activity for months or even years 
after these dates. WHO guidelines also stated that the recently expired antivenoms 
may be useful if there is no alternative treatment in case of severe envenoming [level 
of evidence E]
[31]
. An unpublished data revealed polyvalent ASV in India was found 
to be more effective with Indian cobra and saw scaled viper bites, whereas it was less 
effective in Russell‘s viper and common krait.   
ADVERSE EFFECTS 
 Apart from the efficacy of ASV, the possibility of adverse reactions by 
activation of the immune system is of at most importance in the management of snake 
bite. WHO has classified as i) Early anaphylactic reactions; ii) Pyrogenic (endotoxin) 
reactions; and iii) Late (serum sickness type) reactions
[32]
. 
Early Anaphylactic reactions 
 These reactions are the earliest and the first to occur within 10-180 minutes just 
after administration on while administration. They IgE mediated or non IgE mediated 
reactions mostly characterized by itching, urticaria, fever, nausea, vomiting, 
abdominal colic, diarrhea and tachycardia. Some patients develop characteristic 
anaphylaxis (hypotension, angioedema, bronchospasm). 
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 IgE mediated reactions 
o Previous exposure to equine immunoglobulins leads to IgE antibody 
production which upon administration of ASV interact with the IgE 
receptors on the basophils and mast cells induces cell degranulation and 
release of mediators. 
o Other hypothesis is the presence of antibiotics in antivenom which has 
been found when horses were treated for infections. This triggers IgE 
mediated response 
 Non IgE mediated Reactions 
o Majority of the observed reactions fall under this category.  
o Antivenom anticomplimentary activity (ACA) and heterophilic 
antibodies play an important role in the pathology. 
o Blood, blood products, and therapeutic immunoglobulins causes 
anaphylactoid reactions (mast cell degranulation by non immunological 
mechanisms) without prior exposure by formation of immune 
complexes and subsequent activation of complement cascade
 [33]
. 
o Anaphylotoxins (C5a, C4a, and C3a) stimulate chemotaxis, 
degranulation of mast cells and release of pharmacologically active 
mediators of immediate hypersensitivity reactions
 [34]
. 
o Heterophilic antibodies pave their way into the human plasma through 
vaccines or ingested food. 
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Pyrogenic (endotoxin) reactions 
 These occurs 1-2 hours post treatment which is characterized by fever, chills, 
rigors, nausea, malaise, headache, hypotension. Children suffer from febrile 
convulsions. The main cause of this reaction is the contamination of antivenom by 
bacterial endotoxin (lipopolysaccharide) during the process of manufacture. The 
molecular mechanism states that the interaction with toll like receptors and/or 
lipopolysaccharide binding protein receptors activates monocytes and the immune 
system leading to TNF and cytokine production
 [35]
. 
Late reactions (serum sickness type) 
  These reactions occur between 1-12(mean 7) days after treatment 
characterized by fever, arthralgia, myalgia, lymphadenopathy, recurrent urticaria. 
They are IgG mediated type III hypersensitivity reactions. Antigen-Antibody 
complexes are responsible for late reactions which activates the complement pathway. 
These complexes activate the acute inflammatory response that leads to compliment 
activation and leukocyte infiltration.  
The early institution of ASV is beneficial in preventing complications however 
severe is the systemic envenomation
 [36]
. Attempts to prevent early reactions which 
included pretreatment with epinephrine, antihistamines, corticosteroids and reduction 
in speed and concentration of intravenous antivenom administration have not been 
effective in adequately designed clinical trials
 [37-39]
.Patients with 
hypogammaglobulinemia are more susceptible to serum reactions than others
 [40]
. 
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Contraindications to antivenom 
There are no absolute contraindications to antivenom treatment till date. 
Patients who have exposed to horse (equine) or sheep (ovine) serum in the past (for 
example, after treatment with equine anti-tetanus serum, equine antirabies serum or 
equine or ovine antivenom) and those with a strong history of atopic diseases 
(especially severe asthma) are at high risk of severe reactions and should therefore be 
given antivenom only if they have signs of systemic envenoming. 
MANAGEMENT OF SNAKE BITE 
IN FIELD 
 Early management to be started as soon as possible. The traditional methods 
have been found harmful than good. Delayed transport of the victim to the nearest 
health care Centre with anti-snake venom should be discouraged. The first aid being 
currently recommended is based around the mnemonic: ―Do it R.I.G.H.T.‖ 
R =Reassure the patient. 70% of all snakebites are from non-venomous species. Only 
50% of bites by venomous species actually envenomate the patient. 
I = Immobilize in the same way as a fractured limb.. Do not apply any compression in 
the form of tight ligatures, they can be dangerous! 
G.H. = Get to Hospital Immediately. Traditional remedies have NO PROVEN benefit 
in treating snakebite. 
T = Tell the doctor of any systemic symptoms such as ptosis that manifest on the way 
to hospital. 
 
 
46 
 
Tourniquet: not recommended due to risk of arterial compression which may lead to 
gangrene with a tight tourniquet. If the patient presents with tourniquet applied 
elsewhere, it is recommended not to remove the tourniquet until medical treatment is 
started. Check for distal pulses, if absent remove tourniquet immediately with gradual 
release (sudden release will increase the surge of venom circulation) of pressure. If 
distal pulse is present, avoid removing tourniquet, until ASV is administered.  
Don‟ts 
Do not attempt to suck the venom through mouth 
Do not attempt to capture or kill the snake 
Do not hold a dead snake by the head 
Do not wash with soap or any solutions over the site of bite. 
Don‘t cut or incise the bite mark 
Measures during transport include: 
 Oxygenation if the patient is not maintaining saturation (oxygenation masks the 
early sign of respiratory failure) 
 Stabilize airway breathing circulation. 
 Identify the ptosis, ophthalmoplegia and other neurological symptoms. 
 Watch for paradoxical respiration (abdomen expands rather than the chest, 
while attempted inspiration). 
 Secure intravenous line and rush fluids. 
Management in Hospital 
 Assessment and stabilization of airway, breathing, and circulation. Monitor for 
gurgling/ whistling/ noisy breathing to evaluate airway patency. Head tilt / chin lift / 
 
 
47 
 
jaw thrust maneuver to be followed if airway is compromised. Bag mask ventilation 
followed by CPR if the patient is not breathing. Advanced airway support if needed 
(mostly in neurotoxic snake bite envenomation). Rush fluids for rapid and low volume 
pulse with hypotension. 
Management after stabilization 
Quick history:  where did the snake bite occur (sleeping on ground peculiar for 
Krait), when was the snake bite, what part of body was bitten. How does the person 
feel now (dizziness and faint, difficulty in breathing) 
 Ask questions as to what the victim was doing at the time of the bite. Feeding 
stock animals, grass cutting can be suggestive of snakebite. A short history of 
the status of snake bite and the progression of local and systemic signs is very 
important. Fang marks are evident for the doctor that the patient has been bitten 
by a snake. 
 Bite marks are of no use in identifying if a species is venomous or not though 
in some countries bite marks have limited use in determining species. Many 
non venomous species leave just two fang-like marks e.g. Wolf Snakes. Some 
species like the Krait may leave no bite mark at all. Many venomous species 
grow reserve fangs in case the main ones break off. 
 Determine the exact time of the bite can provide warnings regarding the 
progression of symptoms. Only few symptoms can be elicited if the patient has 
arrived at the hospital soon after the bite irrespective of the amount of venom 
injected. If the patient was bitten at night while asleep, a krait was probably 
implicated; if in a paddy field, a cobra or Russell‘s viper; if while tending fruit 
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trees, a green pit viper; if while swimming or wading in water a cobra (fresh 
water) or sea snake (sea or estuary).  
 A common early symptom of systemic envenoming is vomiting. Patients who 
become defibrinogenated or thrombocytopenic may begin to bleed from old, 
partially-healed wounds as well as bleeding persistently from the fang marks. 
The patient should be enquired about the amount of urine passed. Patients who 
complain of drowsiness, drooping eyelids or blurred/double vision are 
suggestive of neurotoxic envenoming. Generalized pain, tenderness and 
stiffness of muscles and trismus develop within 30 minutes of sea snake 
envenoming. 
 Where possible identify the snake responsible. The color of the snake is 
unreliable in determining the snake species. The victim or their attenders shall 
carefully bring the killed snake to hospital. The identification of snake species 
and management would be helpful if the snake has been killed and brought by 
the attenders or the patient. If it is obviously a harmless species (or not a snake 
at all!), the patient can be quickly reassured and discharged from hospital. 
 Determine if any traditional medicines have been used. Traditional treatments 
can cause problems, in addition to the time taken to administer them. For 
example, the ingestion of herbal or other products can generate symptoms that 
confuse the diagnosis. In some areas the ingestion of clarified butter or ‗ghee‘ 
is a common remedy use to induce vomiting. The rationale is that venom is 
thus vomited from the body. The victim‘s vomiting may be entirely unrelated 
to envenomation. 
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 Obtain a brief medical history (e.g., date of last tetanus immunization, use of 
any medication, presence of any systemic disease, and history of allergy) 
Identify the syndrome: 
1. No envenomation  (local & systemic- nonpoisonous snake or dry bite) 
2. Local swelling only – nonpoisonous snake 
3. Local cellulitis with bleeding manifestation (all vipiridae) 
4. Local cellulitis + bleeding manifestation + neuroparalysis + dark urine 
(Russell‘s viper) 
5. Local cellulitis + neuroparalysis (Cobra) 
6. Only neuroparalysis (Krait) 
7. Paralysis with dark urine (Russell‘s or sea snake) 
If asymptomatic- observe for 24hrs since snake bite can cause late serum sickness of 
type III hypersensitivy reaction. 
Signs of envenomation 
A. Local examination  
1. Fang Marks 
2. Local Pain 
3. Local Bleeding 
4. Bruising 
5. Lymph Node Enlargement 
6. Blistering 
7. Local Infection/Abscess Formation 
8. Necrosis  
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B. Signs of neurotoxic envenomation 
1. Ptosis  
2. Ophthalmoplegia – paralysis of the extra ocular muscles results in 
diplopia 
3. Broken neck sign (due to paralysis of neck flexing muscles, the neck 
falls back when you lift the patient up the shoulder) – Krait 
envenomation 
4. Paradoxical respiration  
C. Signs of bleeding manifestation 
D. Single breath count (normally more than 20): consider advanced airway of 
less than 16 in an adult 
Pregnant Women  
Watch for fetal distress, vaginal bleeding, threatened abortion, monitor uterine 
contraction and fetal heart rate. Lactating women should be encouraged to breast feed. 
INVESTIGATIONS 
Bedside 
20 minute whole blood clotting time (WBCT) 
 5 ml of blood withdrawn in dry glass test tube and left undisturbed for 20 
minutes. At the end of 20 min, the test tube is slightly tilted to look for clot formation. 
Normally the blood is fully clotted by this time but in haemotoxic snake poisoning, 
the time taken for clotting is prolonged and the blood may still be liquid in 20 
minutes. The patient is re-tested every hour for the first three hours and then 6 hourly 
for 24 hours until either test result is not clotted or clinical evidence of envenomation 
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to ascertain if dose of ASV is indicated. In case test is non-clotting, repeat 6 hour after 
administration of loading dose of ASV. In case of neurotoxic envenomation repeat 
clotting test after 6 hours. This is a useful bedside test to diagnose haemotoxic 
envenomation. 
Laboratory  
1. Hemoglobin 
2. Platelet count 
3. Prothrombin time 
4. aPTT 
5. Urine examination for RBC, hemoglobin, myoglobin 
6. Serum Creatinine, urea, electrolytes. 
7. ABG if facilities are available 
8. Complete blood counts 
9. Glucose  
10. Creatinine phosphokinase 
INDICATIONS FOR ASV THERAPY 
Anti-snake venom is the definitive treatment of snake bite envenomation and is 
the cornerstone of management. Systemic envenomation and severe local 
envenomation are indications for administering ASV to a patient. It is important to 
identify systemic envenomation early so that ASV can be administered as soon as 
possible before the venom becomes tissue-bound. ASV is effective only against freely 
circulating venom proteins and not against the tissue-bound proteins. If there are no 
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signs of systemic or severe local envenomation, it is advisable to monitor the patient 
for 24 hours and repeat a whole blood clotting time before discharge 
ASV for neurotoxicity  
  In case neurotoxicity, administer 10 vials of ASV along with prophylactic 
adrenaline. The patient is then kept under observation for 1 to 2 hours. If there is 
worsening of neurological deficits for persistence of weakness after 1 to 2 hours, 
repeat 10 vials (100 ml) of ASV. 
ASV for haemotoxicity 
 In case of haemotoxicity, administer 10 vials of ASV along with prophylactic 
adrenaline. Check the whole blood clotting time 6 hours after administration of the 
dose if the WBCT is more than 20 minutes or of there is clinical bleeding 1 to 2 hours 
after the dose, repeat the dose of 10 vials (100ml of ASV). Administering more than 
20 vials of ASV is probably not beneficial and not recommended. 
Low dose protocol for haemotoxicity 
The problem with the usual regimen is that, 20 vials of ASV cost about Rs.20, 
000 which is beyond what most patients can afford in India. Moreover the dosage of 
ASV is based on WHO recommendation of Southeast Asia. This may be more than 
what is required in individual patients. To address these issues several low dose 
regimens have been studied. Low dose protocol is used for haemotoxicity typically 
from a viper bite and not advisable for envenomations presenting with neurotoxicity. 
Administer 2 vials over 30minutes followed by 2 vials over 2 hours and then 2 vials 
over 4 hours. If there is evidence of clinical bleeding after 1 to 2 hours of starting the 
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dosing or, if the WBCT done after 6 hours of starting the dose is more than 20minutes, 
repeat 4 vials over 6 hours. 
Late-onset envenoming 
The patient should be kept under close observation for at least 24 hours. Many 
species, particularly the Krait and the Hump-nosed pit viper (Joseph et al, 2006) are 
known for the length of time it can take for symptoms to manifest. Often this can take 
between 6 to 12 hours. Late onset envenoming is a well-documented occurrence. In 
many cases of Common krait bites in West Bengal, bilateral ptosis appeared after 24- 
36 h after admission for pain abdomen. 
ASV in pregnant women 
Pregnant women are treated in exactly the same way as other victims. The 
same dosage of ASV is given
[41,42]
. 
ASV dose in children 
Children are also given exactly the same dose of ASV as adults as snakes inject 
the same amount of venom into children and adult. Infusion: liquid or reconstituted 
ASV is diluted in 5-10 ml/kg body weight of normal saline. However, reduce amount 
of fluid in running bottle to 200 ml to avoid fluid over load 
Recurrent envenomation 
Unless proven recurrence no further ASV should be administered if 
coagulation is restored. If the patient comes with features of coagulopathy, ASV is to 
be administered (10 vials). There is no need to give prophylactic ASV to prevent 
recurrence. Recurrence has been a mainly US phenomenon, due to the short half-life 
of Crofab ASV. Indian ASV is a F (ab)2 product and has a half-life of over 90 hours 
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and therefore is not required in a prophylactic dose to prevent re-envenomation. But if 
the patient comes even after a few days reinstitute ASV therapy, because sometime 
absorption of snake venom depot under skin is erratic. If there is no improvement 
from the beginning of the whole blood clotting time, and it goes on increasing, then 
we are dealing with the snake bites which are not amenable to our usual polyvalent 
ASV
[41]
. It is rare for a patient to be bitten again, following a bite from a venomous 
species However, some professions like Herpetologists and snake charmers are prone 
to repeated venomous snakebite. The dosage schedule for ASV in the event of a 
second bite is, however, unchanged. The same starting dose and repeat dose schedule 
as for a normal bite applies. 
First aid for venom spit ophthalmia 
1. Venom coming into contact with eyes can cause intense conjunctivitis with a risk of 
corneal erosions, complicated by secondary infection, anterior uveitis and even 
permanent blindness.  
2. Irrigate the eye or other affected mucous membrane as soon as possible using large 
volumes of water or any other available bland fluid. Never use chemical solutions or 
petroleum products such as petrol or kerosene. Milk is soothing and can be used, or in 
an emergency beer or urine are possibilities. Keep irrigating the eyes, hold them under 
a slowly running tap for a several minutes, while opening the eyelids and rotating the 
eyeball. The eye will be very painful, so patience, tact and reassurance are needed. 
3. The eye should be bandaged using a pad over the eye and dark glasses worn. 
4. Don‘t let the victim rub the eye. 
5. Seek urgent medical attention
[43]
. 
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No evidence of systemic spread of venom from ocular spitting exposure, the 
use of intravenous antivenom unjustified and risks anaphylaxis. 
The use of current textbooks and medical education do not adequately prepare 
doctors to treat snake bite, particularly in the areas of use of ASV, dealing with 
adverse reactions to ASV and specific measures to deal with neurotoxic bites. Local 
protocols and training are required to adequately prepare doctors to improve treatment 
and reduce mortality
[44]
. 
Desensitization procedure only in case of severe anaphylaxis reaction to ASV 
Pre-medication: Administer Inj. Hydrocortisone 100 mg I.V. and Inj. Adrenaline 0.5 
ml subcutaneously/Intramuscularly (+/- Promethazine) 
STEPS OF DILUTION OF ASV 
STEP 
 
INSTRUCTIONS TOTAL 
VOLUME 
SOLUTION DILUTION 
1. Dilute 1 ml of ASV in a vial with 
10 ml of normal saline 
10ml A  
2. 1ml of solution A + 9 ml of saline 10 ml B 1: 10 
3. 1ml of solution B+ 9 ml of saline 10 ml C 1: 100 
4. 1ml of solution C + 9 ml of saline 10 ml D 1: 1000 
5. 1ml of solution D + 9 ml of saline 10 ml E 1: 10,000 
After dilution and preparation of Solution E, Inject 0.1ml of solution E IV followed by 
1ml and then the entire solution E. continue the same process for solution D,C,B,A 
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respectively and then the full dose. Watch for anaphylaxis in every administration OD 
the ASV dilution. 
RECOVERY SIGNS 
 Bleeding stops within 15 - 30minutes. 
 Blood coagulability is usually restored in 6 hours. Principal test is 2OWBCT. 
 Post synaptic neurotoxic envenoming such as in Cobra bite, improve as early as 
30minuutes to several hours. 
 It takes more time to improve neurotoxic envenoming, reflecting the need for 
the body to generate new acetylcholine emitters. 
 Active haemolysis and rhabdomyolysis may cease within a few hours and the 
urine returns to its normal colour. 
 In patients with Shock, blood pressure may increase after 30 minutes. 
Drugs not to be used in viper bites 
Heparin has been proposed as a means of reducing fibrin deposits in DIC. 
However, heparin is contraindicated in Viper bites. Venom induced thrombin is 
resistant to Heparin, the effects of heparin on antithrombin III(ATIII) are negated due 
to the elimination of ATIII by the time Heparin is administered and heparin can cause 
bleeding by its own action. Trial evidence has shown it has no beneficial effect.  
           Botropase is derived from the venom of one of two South American pit vipers 
is a coagulant compound. It prolongs the coagulation abnormality by causing 
consumption coagulopathy in the same way as the Indian viper venom currently 
affecting the victim so it is not used. 
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MATERIALS AND METHODS:  
Study Centre: 
The study was conducted at Dhanalakshmi Srinivasan Medical College and 
Hospital, Perambalur after obtaining institutional ethical clearance from Institutional 
Ethical Committee. Cases of snake bite admitted to three hospitals were included for 
the study after getting permission from the respective authorities (Government 
secondary care centers at Perambalur and Ariyalur district, and a private hospital at 
Erode). 
Study Period: The study was carried out from January 2016 to December 2016. 
Inclusion criteria: 
• All patients who were admitted with complaints of snakebite during the study 
period were considered for the study 
Exclusion criteria: 
• Cases of unknown bite or who lacked evidence of snake envenomation were 
excluded. 
Methodology 
  The relevant details of the study population were collected from three different 
areas and entered in a proforma (Annexure II b) which included the demographic and 
clinical profile, type of envenomation, details of ASV used and its adverse effects, 
outcome of the patient. Inj. ASV used in this study were from three manufacturers 
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namely Biovins, Biological.E.limited and Bhart serums which were depicted in this 
study as ASV I, ASV II and ASV III.  
COMPOSITION OF ASV USED 
BioVins Biological.E.limited Bharat Serum 
Cobra                   : 0.6 mg 
Common Krait       : 0.45 mg 
                                              Russell‘s Viper       : 0.5 mg 
Saw-scaled Viper   : 0.45 mg 
Preservative : cresol 
0.25% 
 
Preservative : phenol 
0.25% 
Preservative : cresol 
0.25% 
Stabilizer : Glycine I.P 
Excipients : Mannitol I.P 
and Sodium Chloride I.P 
    (The Batch number and manufacture date varies accordingly) 
The management of snakebite is as follows: 
 Each case of snake bite was admitted and thoroughly examined by the treating 
doctor. After Securing airway the patient was subjected to Whole Blood 
Clotting Test (WBCT). 
 Haemotoxic snake bite is characterized by WBCT >20minutes / presence of 
bleeding diathesis. They were administered 1 vial of ASV in 250-500 ml of 
normal saline at the rate of 10-15 drops/min over 15 minutes and was looked 
for signs of any adverse reactions. If no reactions were elicited, 7 more vials 
were added in that normal saline and administered over a period of one hour. If 
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repeat CT>20minutes and bleeding diathesis persists even after 6 hours, 5 vials 
was administer in 250-500ml normal saline over one hour. Two more times of 
5 vials was repeated, if there is a bleeding tendency and CT>20 minutes. On 
persistent bleeding diathesis fresh frozen plasma or packed cells was 
administered.  
 If WBCT is normal and the patients presents with signs of neurotoxicity such 
as dysphagia, diplopia, ophthalmoparesis or respiratory distress, ASV was 
administered same as the above. Patient was reassessed after 2 hours and if 
signs of envenomations persist or worsen, 8 more vials were added. 
Inj.Atropine 0.6mg IV, Inj. Neostigmine 1.5mg IM., was administered and 
Ventilator support was needed in cases of respiratory support.  
 All the patients were monitored for a period of 12 to 24 hours  
 For those who had any anaphylactic reactions, Inj. Epinephrine 0.5mg of 
1:1000 solution IM (Repeat dose 10-15 minutes apart), Inj. Chlorpheniramine 
2cc IM, Inj Ranitidine 50mg IV, Normal saline 500-1000 ml IV rapidly, Inj 
hydrocortisone 300-500mg IV was administered. 
Causality and ADR severity assessment: 
 The data obtained were subjected to causality assessment using Liverpool 
algorithm (Annexure II c) and the ADR severity assessment using Modified Hartwig 
Seigel scale (Annexure II d). 
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Statistical Analysis 
Data obtained was recorded in a structured case record form which was entered 
in excel format and analyzed using SPSS 16 software. Descriptive statistics, 
percentages was used for analysis. P value of 0.05 was taken as statistically 
significant. Chi square test was used to check the test of significant between 
associated factors. 
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RESULTS: 
In this study, 476 patients were included. 370(77.73%) patients were from 
perambalur district, 64(13.44%) patients from Ariyalur district and 42(8.82%) patients 
from Erode district. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Perambalur 370 
Ariyalur - 64 
Erode – 42 
476 Cases of Snake 
Bite 
Asv Administered 206 
Ariyalur – 21 
Perambalur 143 
Erode – 42 
ASV I -  63 
ASV II - 101 
ASV III - 42  
Adverse Reactions 55 
ASV I -  17/63 
ASV II - 25/101 
ASV III – 13/42 
Death  - 4 
Referred – 11 
Absconded – 32 
AMA – 4  
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Figure 1: AGE WISE DISTRIBUTION OF SNAKE BITE VICTIMS 
 
 
 
345 (72.5%) of the patients in this study belong to adult age group (20 to 59 years). 
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Figure 2: MONTH WISE DISTRIBUTION OF SNAKE BITE VICTIMS 
 
 
 
90 (19%) cases of the study population was exposed to snake bite the month of 
September and the least exposure was during February (12).  
 
JAN FEB
MA
R
APR
MA
Y
JUN JUL AUG SEP OCT NOV DEC
No of Patients 26 12 13 21 37 47 43 62 90 54 55 16
26 
12 13 
21 
37 
47 
43 
62 
90 
54 55 
16 
0
10
20
30
40
50
60
70
80
90
100
C
A
S
E
S
 
 
 
64 
 
Figure 3: SEASONAL VARIATION OF SNAKEBITE CASES 
 
 
 
 
55% of the study population was exposed to snake bite between  august and 
November. 
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Figure 4: OCCUPATIONAL DISTRIBITION IF THE STUDY POPULATION 
 
 
 
 
342 (71.9%) Laborers were commonly affected among the study population. 43 
(9.03%) students were also exposed to snake bite in this study.   
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Figure 5: TIME OF ADMISSION OF THE STUDY POPULATION 
 
 
 
 
Around 43.9% of the patients were exposed to snake bite during the time period 
between 6pm to 12am. 
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Table 5: DISTRIBUTION OF PRE-HOSPITAL INTERVENTION  
AMONG SNAKE BITE VICTIMS 
 
 
 
INTERVENTION 
 
NO OF PATIENTS (%) 
Nil 414 (87) 
TOURNIQUET 21 (4.4) 
INJ TT 20 (4.2) 
TURMERIC (topical) 9 (1.9) 
HERB 
(Andrographis paniculata – 
Siriyanangai) 
 
12 (2.5) 
 
Almost 87% of the patients did not receive any pre hospital intervention. Topical 
application of turmeric and ingestion of herb-Andrographis paniculata (Siriyanangai) 
were also administered in 20 (4.2%) and 12 (2.5%) patients respectively. 
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Figure 6: CLINCAL MANIFESTATIONS OF SNAKE BITE VICTIMS 
 
 
 
Almost 85% of the snake bite victims had pain as the most  common symptom. 
Ptosis (13), dyspnea (16) and drowsiness (13) were most common in neurotoxic snake 
bites. 
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Figure 7: DISTRIBUTION OF SNAKEBITE VICTIMS ACCORDING 
TO THE TYPE OF ENVENOMATION 
 
 
 
166 (34.9%) had WBCT > 20. 61% of the cases had local envenomation in the study 
population.2% had haemotoxic and neurotoxic envenomation. 
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Figure 8: DISTICT WISE DISTRIBUTION OF VARIOUS ENVENOMATIONS 
 
 
 
Local envenomation was more common among all the snake bite victims in the study 
population. Especially in Perambalur District where 61.35% patients had local 
envenomation. 
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Table 6: APPROXIMATE TIME BETWEEN SNAKE BITE AND 
ADMINISTRATION OF ASV 
 
 
 
 
 
Almost 82.5% of the cases had reached the hospital within 1 hour and was 
administered with ASV. Only 2 patients reached after 12 hours of snake bite  
exposure. 
 
 
 
BITE TO NEEDLE TIME (hours) NO OF PATIENTS (%) 
<1 170 (82.5) 
1 to <3 24 (11.6) 
3 to <6 7 (3.39) 
6 to <12 3 (1.4) 
>12 2 (0.9) 
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Figure 9: DISTRIBUTION OF THE ASV MANUFACTURERS 
 
 
 
All the cases who were administered ASV received it according to the availability of 
type of manufacturer. 
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Figure 10: DISTRIBUTION OF ADVERSE REACTION OF ASV 
 
 
Out of 206 patients administered with Anti Snake Venom, 55 (26.7%) cases had 
adverse reactions in this study population. 
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Table 7: DISTRIBUTION OF REACTIONS AMONG THREE DISTRICTS 
 
 
 
Adverse reactions were observed in 35/143 cases in Perambalur, 5/21 cases in 
Ariyalur and 15/42 cases in erode.  
 
 
 
 
 
  
DISTRICTS 
 
 
TOTAL  
PERAMBALUR (%) 
 
ARIYALUR(%) 
 
ERODE(%) 
ASV 
ADMINISTERED 
 
143 (69.41) 
 
21 (10.19) 
 
42 (20.38) 
 
206 (43.3) 
 
REACTIONS 
 
35 (24.3) 
 
5 (23.8) 
 
15 (36.6) 
 
55 (26.7) 
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Table 8: DISTRIBUTION OF REACTIONS RELATED TO TYPE OF 
ENVENOMATION 
 
 
TYPE OF 
ENVENOMATION 
REACTIONS 
TOTAL 
PRESENT (%) ABSENT (%) 
LOCAL 6 (23.07) 20 (76.93 ) 26 
HAEMOTOXIC 39 (27.08) 105 (72.92 ) 144 
NEUROTOXIC 8 (29.62) 19 (70.38 ) 27 
HAEMOTOXIC / 
NEUROTOXIC 
2 (22.22) 7 (77.78 ) 9 
TOTAL 55 (26.7) 151 ( 73.3) 206 
 
39 (27.08 %) adverse reactions observed were among patients with haemotoxic 
envenomation. 8 (29.62 %), 6 (23.07%), 2 (22.22%) adverse reactions among local, 
neurotoxic and haemotoxic/neurotoxic envenomation respectively. 
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Figure 11: DISTRICT WISE DISTRIBUTION OF TOTAL ASV VIALS USED 
PER SNAKE BITE VICTIM 
 
 
More number of ASV vials was used in perambalur district. A maximum of 30 vials 
were used.  
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Table 9: DISTRICT WISE DISTRIBUTION OF ASV VIALS USED PER 
SNAKE BITE VICTIM 
 
 
 
DISTRICT 
 
NUMBER 
OF 
PATIENTS 
 
MINIMUM 
 
MAXIMUM 
TOTAL 
VIALS 
USED 
 
MEAN±SD 
 
PERAMBALUR 
 
143 
 
1 
 
30 
 
1853 
 
12.76±6.29 
 
ARIYALUR 
 
21 
 
1 
 
20 
 
206 
 
9.81±6.01 
 
ERODE  
 
42 
 
2 
 
16 
 
271 
 
6.56±4.17 
 
TOTAL 
 
206 
 
1 
 
30 
 
2330 
 
11.59 ± 6.38 
 
Total ASV vials used were 2330 and the Mean ASV vials used were 11.59 ± 6.38 in 
this study. 
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Table 10: DISTRIBUTION OF ASV VIALS AMONG THE HAEMOTOXIC 
AND NEUROTOXIC SNAKE BITE 
 
 
 
 
 
TYPE OF 
ENVENOMATION 
 
TOTAL ASV 
VIALS USED 
 
MEAN VIALS 
USED 
 
RANGE 
 
HAEMOTOXIC  
 
 
1634 
 
11.5±5.6 
 
1 to 30 
 
NEUROTOXIC  
 
392 
 
17±6.1 
 
5 to 26 
 
11.5 ± 5.6 and 17 ± 6.1vials were used among haemotoxic and neurotoxic snakebite. 
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Figure 11: DISTIBUTION OF ADVERSE REACTIONS AMONG THREE ASV 
MANUFACTURERS USED 
 
 
 
ADVERSE 
REACTION 
ASV I ASV II ASV III 
PRESENT (%) 17 (26.9) 25 (25.74) 13 (30.9) 
ABSENT  46  76 29 
TOTAL                   63 101 42 
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Figure 12: MANUFACTURER WISE DISTRIBUTION OF TOTAL ASV 
VIALS USED 
 
 
 
ASV II was the most commonly used manufacturer among the study population. 
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Table 13: DISTRIBUTION ADVERSE REACTIONS AMONG THREE 
MANUFACTURERS 
 
 
 
MANUFACTURER 
 
REACTION 
PRESENT (%) 
 
REACTION 
ABSENT (%) 
 
TOTAL 
ASV I 17  (26.9) 46 (73.1) 63 
ASV II 25 (24.75) 76 (75.24) 101 
ASV III 13 (30.9) 29 (69.04) 42 
TOTAL 55 (26.7) 151 (73.3) 206 
 
 P-value = 0.746 (>0.05). 
 A non significant P value determines that there is no relationship in the 
incidence of adverse reaction between the type of manufacturer and adverse 
reactions. 
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Table 14: DETERMININATION THE STRENGTH OF ASSOCIATION OF 
ADVERSE REACTIONS BETWEEN ASV-I & ASV-II 
 
 
 
MANUFACTURER 
REACTION 
PRESENT 
REACTION 
ABSENT 
TOTAL 
ASV I 17 46 63 
ASV II 25 76 101 
TOTAL 42 122 164 
 
 P-value = 0.7501 (>0.05). 
 On comparing ASV I and ASV II, there is no significant change in 
relationship between the manufacturer and incidence of adverse reaction. 
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Table 15: DETERMINATION THE STRENGTH OF ASSOCIATION OF 
ADVERSE REACTIONS BETWEEN ASV-II & ASV-III 
 
 
 
MANUFACTURER 
REACTION 
PRESENT 
REACTION 
ABSENT 
TOTAL 
ASV II 25 76 101 
ASV III 13 29 42 
TOTAL 38 105 143 
 
 P-value = 0.4446  (>0.05). 
 On comparing ASV II and ASV III, there is no significant change in 
relationship between the manufacturer and incidence of adverse reaction. 
 
 
•   
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Table 16: DETERMINATION THE STRENGTH OF ASSOCIATION OF 
ADVERSE REACTIONS BETWEEN ASV-I & ASV-III 
 
 
 
MANUFACTURER 
REACTION 
PRESENT 
REACTION 
ABSENT 
TOTAL 
ASV I 17 46 63 
ASV III 13 29 42 
TOTAL 30 75 105 
 
 P-value = 0.6592  (>0.05). 
 On comparing ASV I and ASV III, there is no significant change in 
relationship between the manufacturer and incidence of adverse reaction. 
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Table 17: GENDER WISE DISTRIBUTION OF ADVERSE REACTIONS 
OF ASV 
 
 
 
GENDER 
REACTIONS 
TOTAL 
PRESENT (%) ABSENT 
MALE 32 (24.2) 100 132 
FEMALE 23 (31.1) 51 74 
TOTAL 55 (26.7) 151 206 
 
Adverse reactions were more common among female (31.1%) in this study 
population. 
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Table 18: DISTRIBUTION OF ADVERSE REACTIONS RELATED TO  
PRE-HOSPITAL INTERVENTIONS 
 
PREHOSPITAL 
INTERVENTION 
REACTIONS 
TOTAL 
PRESENT (%) ABSENT 
NO 
INTERVENTION 
48 (28.4) 121 169 
TOURNIQUET 3 (27.2) 8 11 
INJ TT 1 (11.1) 8 9 
TURMERIC 
(topical) 
1 (20) 4 5 
HERB 
(Andrographis 
paniculata – 
Siriyanangai) 
2 (16.6) 10 12 
TOTAL 55 (26.7) 151 206 
 
28.4 % of adverse reactions were observed in patients without any pre-hospital 
intervention. 
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Table 19: DISTRIBUTION OF ADVERSE REACTIONS AND NUMBER OF 
ASV VIALS USED 
 
 
 
NO OF VIALS 
REACTIONS 
TOTAL 
PRESENT (%) ABSENT  
1 - 10 32 (58.18) 78 110 
11- 20 19 (34.54) 62 81 
>21 4 (7.3) 11 15 
 
Adverse reactions was more common (58.18%) in the cases who received ASV 
between 1 to10 vials. 
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Table 20: FREQUENCY OF ASV VIALS USED IN HAEMOTOXIC AND 
NEUROTOXIC SNAKE BITE 
 
 
 
 
 
 
DISTRIBUTION OF 
VIALS 
 
 
HAEMOTOXIC (%) 
 
NEUROTOXIC (%) 
 
<10 
 
 
74(51) 
 
5(18.5) 
 
11 TO 20 
 
 
59(40.7) 
 
15(55.6) 
 
>21 
 
 
12(8.3) 
 
7(25.9) 
 
 
 
40.7% cases of haemotoxic envenomation and 55% of neurotoxic envenomation 
required a total of 11 to 20 ASV vials. 
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Figure 14: MONTH WISE DISTRIBUTION OF ADVERSE REACTIONS OF 
ASV-II IN PERAMBALUR 
 
 
 
 
 
 
An important finding in this study revealed, 15/20 patients who received ASV-II in 
the study population had adverse reactions during the month of October. 
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Table 21: DETAILS REGARDING PATIENTS DECEASED DUE TO      
SNAKE BITE 
 
 
PARAMETERS  CASE 1 CASE 2 CASE 3 CASE 4 
Age/Sex 20/male 55/male 37/male 70/male 
District Perambalur Perambalur Perambalur Perambalur 
Snake Identified no  no yes 
(common 
krait) 
no 
Pre-hospital 
intervention 
Tourniquet 
application 
 
no no Herb 
(Andrographi
s paniculata) 
 
Bite to needle time 
(approx.) 
1 hour 1 hour 45 mins 1 hour 
WBCT >20 >20 14 12 
Type Of Envenomation haemotoxic haemotoxic neurotoxic neurotoxic 
ASV Used ASV-I ASV-I ASV-II ASV-I 
Total ASV vials Used 8 20 24 (single 
dose) 
24 
ADR yes 
(anaphylaxis) 
yes (itching) no no 
Outcome cardiac arrest cardiac arrest respiratory 
failure 
respiratory 
failure 
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Figure 15: CAUSALITY ASSESSMENT OF ADVERSE REACTIONS OF ASV 
USING THE LIVERPOOL ALGORITHM 
 
 
 
As per Liverpool algorithm the maximum number of antivenom reactions were 
possible (27) and definite  (17). 
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Figure 16: SEVERITY ASSESSMENT OF ADVERSE REACTIONS OF ASV 
USING MODIFIED HARTWIG AND SEIGEL SEVERITY SCALE 
 
 
 
Our study revealed that maximum number (46) of ASV reaction were moderate in 
nature. 
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DISCUSSION 
This is the first large descriptive study, from a secondary care center of 
Perambalur and Ariyalur districts of Tamilnadu on the clinicoepidemiological profile 
and the treatment outcome of the snake bite cases,. The data reported in India is less 
than 40% as most of the patients prefer for public hospitals
[45]
. During the study 
period, around 476 patients were admitted with snake bite. Bites were common in the 
adult age group of 19 to 59 years (72.4%) with males(64.3%) more affected than 
females (35.7%) which may be attributed to the fact that men in this age group are 
economically active and involved in outdoor activities compared to females. To the 
best of our knowledge majority of studies reported low incidence in female patients. 
Teenagers (36) also played an important role as snake bite victims in this study, 
suggest that more ambulant population is at the highest risk for snake bite in this 
region and have been reported in studies from different places in India. The youngest 
patient recorded was a 2 years old female child bitten at home. 
 Perambalur district topped the highest number of patients (77.7%) when 
compared with Ariyalur district (13.4%) in the study period. Perambalur is inland 
district with no coastal line. It was once a rural area under Tiruchirapalli district has 
been trifurcated at the 1995 and further in the 2007 was bifurcated into Perambalur 
and Ariyalur district. Erode is the largest district by area in the state before its division 
into Tirupur. Erode is bounded by the rivers Palar in the North West and Cauvery in 
the south east. It is characterized with scanty rainfall and a dry weather throughout 
except monsoon season. The study Centre at erode is present at thalavady is 
surrounded by reserved forest which is 244 sq.km. The private hospital was chosen in 
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order to differentiate the type of manufacturer of ASV used. Only 42 patients have 
been reported with snake bite in the private hospital at Erode district. This may be due 
to the fact that cost effectiveness of the ASV plays an important role in management 
of snake bite. Since ASV is free of cost in the government sector, patients prefer a cost 
effective treatment for this dangerous tropical disease.  
 There was a diverse distribution of cases throughout the year. The 
month of September topped the highest number of cases (19%). Most of the Studies 
which have quoted their results had a significant rainfall which was an important 
causative factor to epidemiological exposure to larger interaction of humans for snake 
bites
[46]
. The weather forecast in the earlier years was totally different in the year 
2016. There was a wide range in the season where the monsoon season did not 
provide enough rainfall. There were only drizzles during the raining season which 
does not create a great impact in disrupting the snake habitat. 31% of cases were from 
the months between April and July, 55% during august and November.  
All the three districts of the study areas had agriculture as the major 
occupation. Laborers (72.4%) were more among them. Around 9% of the snake bite 
victims were students of school and college going. The study area being a developing 
urban area has a smaller sq.km which had all the necessary institutions within a 
smaller geographical area. This also influenced the patients not to consider any 
traditional intervention or native treatment. None of the victims adopted either of the 
WHO-recommended first aid methods such as pressure immobilization bandaging or 
local compression pad immobilization. So 87% of the overall patients did not expose 
to any pre hospital intervention. The most common pre hospital intervention in our 
 
 
95 
 
study was the application of tourniquet (21) and administration of parentral tetanus 
toxoid (20). Nine patients used topical application of turmeric and 12 patients used 
topical application of extract of Andrographis paniculata (Siriyanangai). About 
43.9% of the patients have reported to the hospital within 6PM and 12AM where most 
of the incidental exposure to snakes occurs. 
In this study, we found that in majority of cases the exact snake species was not 
identified, even though fang marks and other symptoms suggestive of venomous bites 
were present in these cases. Only 10 snakes were identified in this study (common 
krait -3 & Russel‘s viper -7). The identification of snake bite is more often given a 
lower priority as more number of patients is unable to determine the species. The 
observation that bites were common in lower limb (76.3%) compared to upper limb 
(23.7%) suggest that in most cases the snakes were stepped on inadvertently. This 
may be due to the fact that these bites were quick and defensive bites and the patients 
were had poor visibility in nocturnal bite, unnoticed, immediate transportation to the 
hospital, frequently anxious, frightened to identify the species. Pain (85%) and 
swelling (13%) was the classical clinical manifestation of the victims in our study, 
followed by cellulitis in 20 patients. Ptosis and drowsiness was seen in 12 patients. 
Whole Blood Clotting Time (WBCT) was the gold standard laboratory investigation 
for determining the severity of envenomation. 166 (34.9%) patients had a WBCT >20. 
The geographical variation is not restricted only to the incidence and occurrence of 
snake bite. Species variations are also an important indicator in determining the 
severity of snake bite. In our study local envenomation was the commonest type of 
envenomation among all. 61% of the total patients had local envenomation followed 
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by haemotoxic (31%), neurotoxic (6%). Both the Haemotoxic and neurotoxic (2%) 
envenomation which is more characteristic of Russel‘s viper with both coagulation 
and neurological manifestations. A similar study in Pakistan revealed 84.7% 
haemotoxic, 8.7% neurotoxic and 6.5% haemotoxic/neurotoxic
[47]
. Most of the studies 
reported more number of neurotoxic snake bites in their studies
[48]
. India is a diverse 
country and so does the distribution of poisonous snakes and its toxicology varies. 
This may be one of the reason for the reduced number of death(4) as many studies had 
reported larger neurotoxic victims which caused death. Common Krait was 
responsible for nocturnal human bite and had a larger mortality rate in indian 
scenario
[49]
. In one of the studies from Kerala, only 34% of cases with confirmed 
snake bite (n=586) actually developed signs of envenomation
[50]
. Figure 8 depicts the 
district wise distribution of type of envenomation where 31%, 14%, 52% were 
haemotoxic and 5.4%, 9.4%, 2.4% of the cases were neurotoxic in Perambalur, 
Ariyalur and Erode respectively. The larger number of cases in the perambalur district 
has made it irrelevant to compare the epidemiological variations. 
All the victims with absolute indications were administered Anti snake venom 
as the definitive management. Only 206 (43.3%) patients received Anti snake venom 
from different manufacturers and batch number. 144 out of 371 patients at Perambalur 
and 21/64 patients at Ariyalur were administered ASV in secondary care government 
hospital sector. Whereas all the snake bite victims (42/42) were administered ASV in 
the private hospital at Erode. This may be due to 1) non venomous snake bite, 2) dry 
bites, 3) progressing symptoms (common krait & hump nose pit viper), 4) no visible 
symptoms detected in ongoing envenomation, 5) nonspecific symptoms related to 
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anxiety (palpitations, sweating, tremoulessness, tachycardia, tachypnea, elevated 
blood pressure, cold extremities and paraesthesia). These patients may have dilated 
pupils suggestive of sympathetic over activity. So the initial symptoms of the patients 
is most important which poses a lot of difficulties to the clinicians to diﬀerentiate 
them from early signs of envenoming
[51]
. WHO had reported that Dry bites ranges 
between 10-80% for various poisonous snakes
[52]
. Three manufacturers were used in 
the study areas. ASV-I and ASV-II were used in both Perambalur and Ariyalur district 
hospitals whereas ASV-III was used only in the private hospital at Erode district. As 
described earlier that the smaller geographical area also influence the transportation of 
the victims to the hospital. Around 82.5% of the patients reached the treating hospital 
within 1 hour. Five patients came with organizing symptoms after 6 hours, which is 
more relevant to the classical late onset symptoms seen mostly in common krait and 
hump nosed pit viper. There was only one patient who was admitted after 24 hours.  
A total of 2330 vials were used in our study. Mean of 11.59 ± 6.38 vials were 
given with a range of 0 to 30 vials. 1853 vials were used in perambalur district with a 
mean 12.76 ± 6.29 vials, 206 vials with a mean 9.81 ± 6.01 vials in Ariyalur and 271 
vials with a mean 6.56 ± 4.17 was used in Erode. In a study from Rajasthan, out of 
total 138 patients, cobra bite was found in 15 patients and their mean ASV was 20.67 
± 12.23 vials, 28 patients had unknown bite and their mean ASV was 24.64 ± 14.78 
vials while maximum patients had viper bite (n=82) and their mean ASV was 43.78 ± 
30.41
[53]
. In an another study at Chandigarh, a neonatal snake bite was reported with 
50 vials of ASV administered
[54]
. There has been a variation in the average total 
number of ASV vials used among different regions. In hilly areas like Himachal 
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Pradesh the existence of Trimeresurus albolabris (white lipped pit viper), Gloydius 
himalayanus (Himalayan pit viper) and Naja oxiana (black cobra) has also been 
documented apart from the Big 4
[55]
. A short comparison of different geographical 
regions has been compared below: 
Table 22: ASV Utilization pattern in Haemotoxic and Neurotoxic snake bite 
GEOGRAPHICAL 
AREA 
STATE MEAN ASV USED IN 
HAEMOTOXICITY 
MEAN ASV USED IN 
NEUROTOXICITY 
HILL Kangra, 
Himachal 
Pradesh
[56] 
 
31.2 
 
21.5 
DESERT Bikaner, 
Rajasthan
[57] 
43.78 20.67 
GROUND LEVEL Madurai, 
Tamilnadu
[58,59]
 
12.5 12.8 
The average number of ASV used for snake bite in general is relatively more in 
desert area like Rajasthan, when compared to the ground level/landscape. 
Contradictorily in high altitude areas like himachal Pradesh, the mean ASV used in 
haemotoxic envenomation is lesser in comparison with desert areas. This can be 
explained that the concentration of the venom in snakes (like the concentration of 
sweetness in fruits) will be lesser in high altitude when compared to desert areas.   
  The Maximum dose used was 30 vials in one patient. This may be due to 
various factors such as younger snakes/male gender/ bite after longer period/forceful 
bite etc. For 27.4 % of the patients 8 vials was given as total dose. In most of the 
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occasions ASV utilization is complete. In a study all cases of envenoming were not 
given 10 vials as per protocol and some received only 2 vials and recovered
[60]
. The 
use of protocol reduced the usage of ASV and the number of deaths. Locally 
developed protocols should be encouraged by organization like the World Health 
Organization and national and state level bodies can create those protocols with 
significant input from local experts 
[61]
. There is no evidence in India which shows that 
low dose strategies have any validity. The same problem relates to high dosage 
regimens often based on Harrison‘s textbook of medicine which was written 
specifically for Western scenario and not intended for use in the developing countries 
like India
[62]
.  
There is variability in the efficacy of ASV in India between species, within the 
same species and between different geographical regions. An average of 11.1 ASV 
vials per patient in a study at Manipal
[63]
. Inappropriate dosage is being followed in 
many of the hospitals irrespective of the cost. This occurs mostly in cases of patients 
who are seriously ill with persistent abnormal coagulopathy and neuroparalysis with 
respiratory depression which has led to intensive care. Administration of fixed dose of 
200ml of ASV and anticholinesterase along with ventilator support reverses 
neuroparalysis in severe neurotoxic snake bites
[64]
. One vial of Indian polyvalent ASV 
production costs around US$8–10, which is mostly equivalent to several days of 
salary for poor laborers and so many of them cannot afford the average used 10–15 
vials needed to reverse envenoming
[65]
. Studies have proven that administration of 
ASV to victims with established respiratory paralysis does not reverse paralysis
[66]
. 
This was one of the important reasons where the lack of restoration of the symptoms 
 
 
100 
 
had let to administration of excess amount of antivenom. So cautious use of ASV with 
special concerns about cost and dose is essential for effective management. 
 Adverse reactions were seen in 55 (26.7%) patients. Only early reactions 
were seen in all the patients. Generalized and focal itching were most commonly seen 
in 31 (56.4%) patients, followed by dyspnea (10), nausea and vomiting (10). 
Anaphylaxis was seen in 9 (16.4%) patients. To our knowledge, none of the studies in 
South Asia had reported any death due to adverse reactions and are under-reported.  
Table 23: Various Studies with Incidence of Adverse Reactions 
STUDY AUTHOR/S 
[year] 
DATA SOURCES OR 
LOCATION 
CASES 
REACTIONS 
(%) 
Halesha et al
[67]
[2012] Bengaluru, Karnataka 180 23 (12.7%) 
Mathivani et al
[59]
[2013] Madurai, Tamilnadu 212 127 (59.9%) 
Deshmuhk et al
[68]
 
[2014] 
Ambajogai ,Maharashtra 50 31 (62%) 
Sheik et al
[69]
[2016] Chengalpet, Tamilnadu 77 17 (23%) 
Kumaravel et 
al
[70]
[2016] 
Dharmapuri, Tamil Nadu 
46 
(paediatric) 
3 (6%) 
Poovazhagi et 
al
[71]
[2017] 
Chengalpattu, Tamilnadu 
26 
(paediatric) 
18 (69.2%) 
Raina et al
[72] 
[2017] Himachal Pradesh 200 14(7%) 
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 The range of adverse reactions among the three districts varied accordingly. 35 
(24.3%) in Perambalur, 5 (23.8%) in Ariyalur and 15 (36.6%) in Erode experienced 
adverse reactions to antivenom. The frequency of adverse reactions among 
manufactures showed that ASV-I, ASV-II and ASV-III had 17/61,  25/101 and 13/42 
reactions respectively. The frequency of the adverse reactions among the three 
manufacturers was compared using chi-square test and was found to be insignificant 
(P< 0.05). An attempt of inter-comparison of the three manufacturers to determine the 
strength of association of adverse reaction was carried out.  
ASV-I & ASV-II (P-0.7501), ASV-II & ASV-III (P-0.4446) and ASV-I & 
ASV-III (P-0.6592) stated a non significant association between the manufacturer and 
adverse reaction. Thus different manufacturers of ASV have no association with the 
incidence of adverse reactions. There was no studies traced pertaining to the 
difference in the efficacy of the different manufacturers. Only in vitro studies have 
been dealt with the efficacy parameters. One such study was done in Srilanka which 
compared the in vitro neutralization of srilankan snake venoms with Indian polyvalent 
ASV (VINS & BHARAT). Both the antivenoms failed to neutralize the neurotoxicity 
of Russell‘s viper and VINS antivenom was found to be superior to BHARAT 
antivenom at concentrations equivalent to administering 10 vials of antivenom, based 
on binding and neutralization studies which is inconsistent to measure relevant 
efficacy in the outcomes of humans
[73]
.  
A total of 84 patients received ASV-II in Perambalur district and 20 patients 
had adverse reactions. An important incidental finding in our study was, during the 
month of October patients who were administered ASV-II had the most number of 
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reaction (15) than the other months (5). One of the 4 deceased was among this period.  
This was brought to the notice to the head of the department and the batch of ASV-II 
was changed. The number of reactions was more, compared to the use in other 
months. This has occurred due to the change in the batch number thus proving that 
different batch number of ASV of the same manufacturer also plays an important role 
in the incidence of reactions. A similar scenario was observed in a study at Vellore 
where, batch to batch variability in the efficacy of ASV led discontinuation of that 
particular batch and it was replaced
[74]
. Only 4 patients among the snake bite victims 
died. Respiratory failure (2) and cardiac arrest (2) were the cause of death. This can be 
explained by the fact as mentioned earlier that almost 170 (82.5%) snake bite victims 
reached the hospital within one hour.  A study in the hilly areas of Himachal Pradesh 
had a mortality rate of 13.3% where only 3% of the cases reaching the hospital within 
one hour, 45.4% cases took 1-6 hours while 52% patients presented after 6 hours of 
bite
[75]
. There was no correlation between the snake bite and time taken to administer 
ASV as 84% of the patients reached the hospital within one hour in our study. 32 
(6.7%) absconded from the hospital. These victims were confirmed cases of 
nonpoisonous/dry bite victim and were under observation. Among the snake bite 
victims in the study area most of them were daily laborers who whose daily wages is 
an important factor in running their family they were hesitant to be under observation 
and hence absconded. Some patients also preferred for a sophisticated care and few 
preferred native treatment over allopathy. 4 patients (Erode private hospital) were 
discharged against medical advice In view of financial crisis. 11 patients were referred 
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for superspeciality care. 424 (89%) of the patients were discharged post treatment and 
reviewed after 7 days to the outpatient department. 
A causality assessment was done in this study using the Liverpool algorithm to 
all the patients who had adverse reactions. It was noted that 49% of the patients had a 
score of possible and 31% were definite. The possibilities of 31% of definite score are 
the largest reported than in any other studies as far as our knowledge. This is due to 
the fact that most of the patients were readministerd with antivenom since it is the 
only management available for snake bite. The readministration of the antivenom 
equals rechallenge procedure which resulted in the more number of ―definite‖ scores. 
The surprising score of unlikely (6) and probable (5) does surely predict a less likely 
causality between the ASV and the adverse reactions. This has occurred due to the 
fact that most of the signs and symptoms of the adverse reactions are equal to the 
clinical manifestations of the envenomation. Thus the incidence of ―unlikely‖ and 
―probable‖ scores. 
The severity score was determined by the Modified Hartwig and Siegel 
severity scale. This scale had three classifications of mild, moderate and severe. There 
are also inter-classifications among the three with levels I to VIII. In this study there 
were no cases with mild severity thus assuring that all reaction of the anti-snake 
venom are outrageous. 46 (83.6%) patients had moderate scale (level III & IV). 9 
patients were graded under severe (level V, VI,VII) . This denotes the number of 
patients dead (4) and the patients who required intensive care with or without 
mechanical ventilation. 
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LIMITATIONS OF THE STUDY 
 The storage of the ASV vials were beyond the control of the investigator as to 
whether the ASV used were consistent in quality and concentration which 
might introduce a variability in results of the study. 
 The utilization pattern varied accordingly in the private hospitals and 
government hospitals. 
 The patients were observed only during the inpatient period and the late 
reactions which usually occur after a mean of 7 days post treatment were 
missed. Even after the patients were discharged, the possibilities of the patients 
returning with complaints of late reactions were rare as the symptoms were 
often mistaken.  
 No telephonic communication has been made to know the late reactions if any. 
 Readmission details were not available. 
 Apart from these three study areas, no permission was granted from the 
authorities of other secondary and tertiary care hospitals in nearby districts. 
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SUMMARY AND CONCLUSION 
Rural agricultural and farm workers experience snake bite as the most common 
medical emergency. Preventive measures are still underdeveloped among the study 
population. Though the incidence of ADR is more troublesome, ASV the only safe 
and effective drug in preventing morbidity. Out of 10 snakes identified only 3 had 
adverse reactions. Mostly the patients had local envenomation which proves either 
nonpoisonous snake or dry bite. The present study was able to identify the major 
epidemiological and management variables in snake bite. The patients in the current 
study were treated with limited number of ASV vials (an average of 11.6) when 
compared with the Tamilnadu guidelines of snake bite 2016 (maximum of 24 vials).  
The current era where most of medical expenditure is rising up, optimizing the ASV 
usage becomes one of the important aspects in the treatment. Different manufacturers 
did not show any significant variations in the adverse reactions. Premedication had no 
role in the reduction of adverse reactions. Another important finding from our study is 
that the batch number should also be periodically checked with response to the 
incidence of ADRs. 
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FUTURE ASPECTS 
Clinicians from the other parts of the world have also stated that ASV is 
ineffective as the geographical variations of snakes play an important role. There is a 
definite need to abandon the concept of ―Big 4‖ as the incidence of hump nosed viper 
has been increasingly reported, which is not one among the 4 antivenom derived 
species. Preventive and educational program at the community level with active 
involvement of local organizations. Development of comprehensive check list for 
identification for snake species has to be suggested. Pressure immobilization methods 
recommended by WHO has to be notified to public. 
Since 80% of the venom obtained for manufacturers of india is from single 
geographical region which has led to reduced efficacy rates, the need for venom 
collection from the nearest geographical region is of more important. Snake banks 
should be formed in all states by relevant authorities, thereby increasing the 
production of venom and reduction of manufacturing cost can be made. Improvising 
the quality to be focused on more purified, less allergenic and specific product at 
affordable cost is needed. So, an upgrade in the assessment of quality testing has to be 
organized. Identification of specific neutralizing antibodies for venom proteins can be 
developed. ‗Cocktail antivenom‘ which neutralizes cobra venom proteins and a ‗pan-
specific antiserum‘ against elapids of Asia is under studies[76]. A novel antivenom 
therapy using ‗phage display technology‘ is under recent advancement[77].  
The other important lacunae in the management of snake bite to be effective 
are the identification of the snake or its species. It may be the use of monovalent ASV 
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to reduce the efficacy and ADR or making the clinical management easier by knowing 
the type of envenomation which makes the clinicians to face the known symptoms.  
Table 24: Monovalent/Bivalent/Trivalent antisnake venom used and their 
incidence of adverse reactions 
PLACE/YEAR NO OF 
CASES 
ADVERSE REACTIONS 
Hong kong / 2017
[78]
 191 
(Monovalent) 
Green pit viper antivenom - 4.7%. 
Agkistrodon Halys antivenom - 1.4%. 
costa rica / 1996
[79]
 39 
(Monovalent) 
14 (36%) presented early adverse 
reactions Urticaria (18%) was the most 
frequent early adverse reaction and there 
was no life-threatening anaphylactic 
reaction. 
Sindh, Pakistan / 2017
[80]
 5 (bivalent) Nil. 
Amazon, brazil / 2012
[81]
 102 
(58 bivalent) 
(44 trivalent) 
 
Bivalent -10(17%). 
Trivalent -11(25%). 
 
Monovalent antisnake venom is not available in India. Its advantage being the 
reduction in the total number of vials used and adverse reactions. Since there is a 
reduction in the proper identification of snake species, monovalent antivenoms are not 
used commonly. Most of the government hospitals in Tamilnadu have random images 
for identification of the most common snakes. This can still be improvised by 
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providing different angles and age variations of the snake photos to be displayed and 
interpreted by the patients.  
As whatsapp has made a great deal in an easier way of communication with 
people, its role has also been portrayed to be helpful in management of snake bite. 
+919745003075, +919818062986, +917828392260 are some of the trusted and self-
tested contact numbers for 24 x 7 helpline to provide as much help possible which 
includes getting an expert doctor to talk to the doctor treating the patient and help in 
procuring ASV if there is a need. Indeed the evolution of applications has made a 
greater impact in marketing and so the mobile applications for snake bite 
identification by developers from government or private sectors or together can be 
made feasible. This also helps in avoiding the killing of the snakes, perhaps it‘s an 
offence under Wildlife Protection Act. Snake handling training for public by the forest 
officials is to be encouraged. The above mentioned measures can avoid the 
killing/depletion of this endangered species which in turn avoids the disruption of the 
ecosystem. 
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ANNEXURE – I 
 
   
 
 
 
 
 
 
 
  
 
 
 
 
 
 
Major venomous “Big 4s” 
 
 
 
 
 
 
 
Russell‟s Viper (Daboia russelii) Saw scaled Viper (Echis carinatus) 
Common Krait (Bungarus 
caeruleus) 
Spectacled Cobra (Naja naja) 
Northern Saw scaled Viper 
(Echis sochureki) 
Hump nosed viper 
(Hypnale hypnale) 
King cobra  
(Ophiophagus hannah) 
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Venomous snakes not considered in ASV in India 
 
The venom extraction area at the irula snake catchers industrial cooperative 
society LTD, Vadanemmeli. 
 
 
 
 
Milking of Russel‟s viper venom. 
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The picture showing the extracted venom of Russel‟s viper during the visit to 
Irula the irula snake catchers industrial cooperative society LTD, Vadanemmeli. 
 
The photo of the killed snake (Russel‟s viper) taken by the attenders of snake bite 
victim. 
 
 
112 
 
 
 
Blister formation of the snake (Russel‟s viper) bite victim. 
 
 
Picture describing the information on identification of venomous and 
nonvenomous snakes displayed in the government hospitals of Tamil Nadu. 
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ANNEXURE IIa: MASTER CHART 
s.no 
mont
h age 
s
e
x district occupation 
bite 
mark 
site of 
bite 
time of 
bite 
type/ status of 
snake 
pre hospital 
interventions 
clinical 
profile 
W 
 B 
 C  
 T 
(min
s) 
type of 
envenomation 
ASV 
administered 
batch number 
used 
bite to 
needle 
time 
(approx) 
adverse 
reactions 
vials 
used complications 
1 
jan 
30 
M perambalur farmer yes left foot 
4:30 PM unidentified no 
cellulitis  
>20  
haemotoxic yes 
bio vins 
01AS15012 
16hrs 
anaphylax
is  1 
referred to 
higher centre 
2 
jan 
45 
M perambalur farmer yes 
left 
dorsum 
of foot 
5:00 
AM unidentified yes 
cellulitis 
15 
haemotoxic yes bio vins 
01AS15012 
2hrs nil 
20 
recovered 
3 
jan 
35 
M erode labourer yes  left leg  
7.50 PM unidentified no 
swelling  
16 
local yes 
Bharat 
sr.O12010 
2hrs no 
2 
recovered  
4 
jan 
26 
F erode housewife yes 
right 
hand  8.30AM unidentified no 
swelling 
/blisters  12 
local yes 
Bharat 
sr.O12010 
5hrs no 
4 
recovered  
5 
jan 
60 
F perambalur vendor no 
left 
middle 
toe 
12:00 
PM unidentified yes 
giddiness 
7 
local no 
nil 
no no 
nil 
recovered  
6 
jan 
40 
M perambalur farmer yes 
right 
foot 7:00 PM unidentified yes 
giddiness, 
pain >20  
haemotoxic/ne
urotoxic 
yes 
bio vins 
01AS15012 
2hrs no 
13 
recovered 
7 
jan 
34 
F ariyalur labourer yes left foot 
6:00 PM unidentified no 
giddiness 
8 
neurotoxic yes 
B.E A1602116 
1hr 
anaphylax
is  8 
recovered 
8 
jan 
52 
M perambalur labourer yes 
right 
ring 
finger 
7:00 
AM unidentified no 
giddiness 
/swelling 
>20  
haemotoxic/ne
urotoxic 
yes bio vins 
01AS15012 
1hr no 
20 
recovered 
9 
jan 
65 
F perambalur labourer yes 
right 
foot 4:50 PM unidentified no 
pain, 
swelling 5 
local nil 
nil 
nil nil 
nil 
recovered 
10 
jan 
65 
F erode labourer yes 
right 4 
th finger  
9:00 
AM unidentified no 
pain, 
swelling 17 
local yes 
Bharat 
sr.212008 
1hr no 
2 
recovered  
11 
jan 
28 
M ariyalur maison no 
right 
hand 
11:00 
AM unidentified yes 
giddiness 
/swelling 8 
neurotoxic yes 
B.E A1602116 
1hr no 
nil 
recovered  
12 jan 40 M perambalur labourer no left hand 6:20 PM unidentified no swelling 8 local nil nil nil nil nil recovered 
13 
jan 
60 
M perambalur labourer no 
right 
foot 
4:40 PM unidentified no 
blurring 
of vision, 
cellulitis 8 
neurotoxic nil bio vins 
01AS15012 
1hr nil 
nil 
absconded 
14 
jan 
20 
M perambalur student yes left foot 
4:18 PM unidentified yes 
cellulitis, 
pain >20  
haemotoxic yes 
bio vins 
A05315117 
1hr 
anaphylax
is  8 
death due to 
cardiac arrest 
15 
jan 
51 
F perambalur labourer no left leg 
2:00 PM unidentified no 
pain 
7 
haemotoxic yes 
bio vins 
A05315117 
5hrs nil 
nil 
recovered 
16 
jan 
28 
F ariyalur housewife no right leg 
9:00 PM unidentified yes 
pain 
8 
local no 
nil 
nil nil 
nil 
recovered 
17 
jan 
16 
M perambalur labourer yes 
right 
third toe 8:00 PM C.krait no 
giddiness, 
ptosis 15 
neurotoxic yes 
bio vins 
A05315117 
1hr 
yes. 
itching 8 
referred to 
higher centre 
18 
jan 
50 
F perambalur labourer no left foot 
11:50 
PM unidentified no 
cellulitis 
>20 
haemotoxic yes 
bio vins 
A05315117 
1hr 
yes. 
itching, 
dyspnea, 
chest pain 13 
recovered 
19 
jan 
29 
M perambalur labourer no left foot 
1:20 
AM unidentified yes 
cellulitis  
>20 
haemotoxic yes 
bio vins 
A05315117 
 1 day no 
12 
recovered 
20 
jan 
45 
F perambalur labourer no 
right 
hand 8:00 PM unidentified no 
pain 
6 
local nil 
nil 
nil nil 
nil 
recovered 
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21 
jan 
42 
F ariyalur labourer no right leg 
9:00 PM unidentified yes 
pain/swell
ing >20 
haemotoxic yes 
B.E A1602116 
2hrs 
yes,chills 
& rigor 16 
recovered 
22 
jan 
44 
M perambalur security no 
right 
hand 
7:45 PM unidentified no 
mild 
giddiness, 
pain 6 
local nil nil nil nil nil recovered 
23 
jan 
60 
F perambalur labourer no 
right 
hand 
10:30 
PM unidentified no 
difficulty 
in 
breathing, 
, 
giddiness 8 
neurotoxic  nil 
bio vins 
A05315117 
1hr 
anaphylax
is  
16 
recovered 
24 jan 60 F perambalur labourer no left foot 8:55 PM unidentified no pain 11 local no nil no no nil recovered 
25 
jan 
60 
F perambalur security no 
right 
ankle 5:30 PM unidentified yes 
pain 
7 
local no 
nil 
no no 
nil 
recovered 
26 
jan 
44 
M perambalur garndener yes right leg  
7:45 PM unidentified no 
pain 
>20 
haemotoxic yes 
bio vins 
A05315117 
1hr no 
13 
recovered 
27 
jan 
27 
M perambalur labourer yes 
right 
foot 3:30 PM unidentified no 
pain 
>20 
haemotoxic yes 
bio vins 
A05315117 
1hr no 
18 
recovered 
28 
feb 
35 
M perambalur labourer no left foot 
7:15 PM unidentified no 
giddiness 
9 
neurotoxic yes bio vins 
A05315117 
30 mins 
yes. 
itching, 
pruritis 20 
recovered 
29 
feb 
60 
F perambalur labourer no 
left 
lower 
limb 2:45 PM unidentified no 
pain 
8 
local no 
nil 
no no 
nil 
recovered 
30 
feb 
46 
M perambalur labourer no 
right 
ankle 7:50 PM unidentified yes 
pain 
8 
local no 
nil 
no no 
nil 
recovered 
31 
feb 
42 
M erode labourer yes right leg  
11.40 
AM unidentified no 
pain, 
swelling 9 
local yes 
Bharat 
sr.O12010 
2hrs no 
2 
recovered  
32 
feb 
34 
F ariyalur labourer yes right leg  
11.40 
AM unidentified no 
pain, 
swelling 10 
local yes 
B.E A1602116 
2hrs 
yes,itchin
g 8 
recovered  
33 
feb 
44 
M ariyalur maison yes 
right 
arm 
12:00 
PM unidentified yes 
pain/swell
ing 11 
local yes 
B.E A1602116 
2hrs no 
8 
recovered  
34 
feb 
39 
M perambalur labourer no 
left 
forearm 6:30 PM unidentified no 
pain 
6 
local no 
nil 
no no 
nil 
recovered 
35 
feb 
28 
M perambalur labourer no left foot 
2:50 PM unidentified no 
pain,cellu
litis >20 
haemotoxic  yes 
bio vins 
A05315117 
1hr no 
10 
recovered 
36 
feb 
24 
M perambalur labourer no 
right 
ankle 3:35 PM unidentified no 
pain 
11 
local no 
nil 
no no 
nil 
recovered 
37 
feb 
50 
F erode labourer yes left hand 
12.30 
PM  unidentified no 
pain, 
swelling 13 
local yes 
Bharat 
sr.212008 
 20 mins no 
2 
recovered  
38 
feb 
46 
M perambalur labourer yes right leg  
7:55 PM unidentified no 
pain,swell
ing >20 
haemotoxic  yes 
bio vins 
A05315117 
1hr no 
8 
recovered 
39 
mar 
28 
F perambalur housewife yes left leg 
7:30 PM unidentified yes 
giddines 
and 
fall,swelli
ng, 
lymphade
nopathy >20 
haemotoxic/ne
urotoxic 
yes 
bio vins 
A05315117 
1hr 
yes. 
nausea, 
vomiting 
16   
40 
mar 
23 
F perambalur student no 
right 4th 
toe 1:15 PM unidentified no 
pain,swell
ing 14 
local no 
nil 
no no 
nil 
recovered 
41 
mar 
45 
F perambalur labourer yes right leg  
8:00 
AM unidentified no 
pain,swell
ing >20 
haemotoxic  yes 
bio vins 
A05315117 
1hr no 
18 
recovered 
42 
mar 
42 
F erode labourer yes 
right 
hand  4:00 PM unidentified yes 
swelling 
/blisters  >20 
haemotoxic  yes 
Bharat 
sr.212008 
5hrs 
anaphylax
is  5 
recovered  
43 
mar 
46 
M ariyalur labourer yes 
right 
ankle 
9.00 
AM  unidentified no 
pain,cellu
litis >20 
haemotoxic yes 
B.E A1602116 
1hr no 
13 
recovered  
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44 
mar 
30 
M perambalur labourer yes 
right 
forearm 
10:30 
AM R.viper no 
drowsines
s , 
swelling, 
lymphade
nopathy >20 
haemotoxic/ne
urotoxic 
yes 
bio vins 
A05315117 
8hrs no 
8 
recovered 
45 
mar 
32 
M perambalur housewife yes left foot 
6:00 PM unidentified yes 
difficulty 
in 
breathing, 
, 
giddiness >20 
haemotoxic/ne
urotoxic 
yes 
bio vins 
A05315117 
1hr no 
5 
recovered 
46 
mar 
35 
F perambalur labourer no 
right 
forearm 3:19 PM unidentified no 
pain 
7 
local no 
nil 
no no 
nil 
recovered 
47 
mar 
40 
F perambalur labourer no 
left 
lower 
limb 1:00 PM unidentified no 
pain 
6 
local no 
nil 
no no 
nil 
recovered 
48 
mar 
28 
M erode farmer yes 
right 
third toe 1:00 PM unidentified no 
swelling 
/blisters  >20 
haemotoxic  yes 
Bharat 
sr.O12010 
2hrs itching 
7 
recovered  
49 
mar 
34 
F perambalur labourer yes  
left 
ankle 
11:08 
AM unidentified no 
pain,bliste
rs 
>20 
haemotoxic  yes 
bio vins 
A05315117 
1hr 
yes,breath
llessness, 
epigastric 
pain, 
nausea, 
vomiting 18 
referred to 
higher centre 
50 
mar 
50 
M perambalur security no 
right 
ankle 
12:40 
PM unidentified no 
pain 
11 
local no 
nil 
no no 
nil 
recovered 
51 
mar 
25 
F perambalur housewife yes 
right 
forearm 
5:30 PM 
kannadi 
viriyan no 
dehydrati
on, 
sweating >20 
haemotoxic  yes bio vins 
01AS15040 
1hr no 
18 
recovered 
52 
apr 
30 
F perambalur labourer no 
right 
index 
finger 
10:45 
AM unidentified no 
pain 
6 
local no 
nil 
no no 
nil 
recovered 
53 
apr 
60 
M perambalur labourer no left foot 
8:30 
AM unidentified no 
pain 
7 
local no 
nil 
no no 
nil 
recovered 
54 
apr 
30 
M perambalur labourer yes right leg  
1:40 PM unidentified yes 
pain 
11 
local no 
no 
no no 
no 
referred to 
trichy for arf 
55 
apr 
30 
M perambalur labourer yes left leg 
12:45 
PM unidentified no 
pain and 
bleeding >20 
haemotoxic  yes 
bio vins 
01AS15040 
1hr no 
18 
recovered 
56 
apr 
70 
M ariyalur labourer no 
right big 
toe 8:00 PM unidentified no 
pain 
11 
local no 
nil 
no no 
nil 
recovered 
57 
apr 
46 
M perambalur security no 
left 
lower 
limb 
11:00 
AM unidentified no 
pain 
12 
local no 
nil 
no no 
nil 
recovered 
58 apr 38 M perambalur labourer no left foot 9:00 PM unidentified no pain 7 local no nil no no nil recovered 
59 apr 39 M perambalur labourer no right leg 8:55 PM unidentified no pain 16 local no nil no no nil recovered 
60 
apr 
55 
M perambalur labourer yes left leg 
6:00 
AM unidentified no 
pain,swell
ing >20 
haemotoxic  yes 
bio vins 
01AS15040 
1hr 
yes. 
itching 20 
death due to 
cardia arrest 
61 
apr 
27 
F ariyalur labourer no 
left 
ankle 6:00 PM unidentified no 
pain,swell
ing 8 
local no 
nil 
no no 
nil 
recovered 
62 
apr 
7 
M ariyalur nil yes 
right 
hand 
11:00 
PM unidentified no 
pain 
>20 
haemotoxic  yes 
bio vins 
01AS15040 
1hr no 
13 
recovered 
63 
apr 
21 
M perambalur student yes 
right 
index 
finger 8:00 PM unidentified no 
pain 
>20 
haemotoxic  yes bio vins 
01AS15040 
10 mins no 
23 
recovered 
64 
apr 
19 
M perambalur student no 
left 
lower 
10:02 
AM unidentified yes 
pain 
6 
local no 
no 
no no 
nil 
recovered 
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limb 
65 
apr 
27 
M perambalur labourer yes 
right 
ankle 8:10 PM unidentified no 
pain, 
cellulitis >20 
haemotoxic  yes 
bio vins 
01AS15040 
1hr 
chills & 
rigor 23 
recovered 
66 
apr 
40 
F erode labourer yes  left leg  
4.30 PM unidentified no 
pain, 
swelling >20 
haemotoxic  yes 
Bharat 
sr.O12010 
1hr vomiting 
3 
recovered  
67 
apr 
29 
M erode driver yes right leg  
10:00 
AM unidentified no 
pain, 
swelling >20 
haemotoxic  yes 
Bharat 
sr.O12040 
4 hrs no 
3 
recovered  
68 
apr 
70 
M perambalur labourer yes left foot 
12:50 
PM unidentified no 
pain 
>20 
haemotoxic  yes 
bio vins 
01AS15040 
1hr no 
13 
recovered 
69 
apr 
25 
M perambalur driver yes 
left 
forearm 
10:18 
PM unidentified no 
nausea.vo
miting,chi
l rigor 
,fever 
>20 
haemotoxic  yes 
bio vins 
01AS15040 
1hr 
yes. 
itching, 
urticaria, 
fever, 
nausea 
,vomiting 8 
recovered 
70 
apr 
75 
F perambalur labourer yes 
right 
foot 
7:33 
AM unidentified no 
pain 
>20 
haemotoxic  yes 
bio vins 
01AS15040 
30 mins no 
23 
recovered 
71 
apr 
70 
F perambalur labourer no 
right big 
toe 
10:43 
PM unidentified no 
pain 
8 
local no 
nil 
no no 
nil 
recovered 
72 
apr 
32 
M perambalur labourer no 
left 
thumb 
3:03 
AM unidentified no 
pain 
12 
local no 
nil 
no no 
nil 
recovered 
73 
apr 
50 
F perambalur labourer no 
right 
index 
finger 
9:00 
AM unidentified no 
pain 
11 
local no 
nil 
no no 
nil 
recovered 
74 
may 
58 
F erode labourer yes left leg  
10:00 
AM unidentified no 
pain, 
swelling >20 
haemotoxic yes 
Bharat 
sr.4053140 
20 mins itching 
2 
recovered  
75 
may 
25 
M perambalur labourer no right leg 
10:00 
AM unidentified no 
pain 
9 
local no 
nil 
no no 
nil 
recovered 
76 
may 
45 
M perambalur labourer yes right leg 
2:19 PM C.krait no 
cellulitis 
>20 
haemotoxic  yes 
bio vins 
01AS15040 
30 mins no 
8 
recovered 
77 
may 
45 
M perambalur labourer yes right leg 
2:19 PM unidentified no 
swelling, 
celulitis, 
oliguria >20 
haemotoxic  yes bio vins 
01AS15040 
1 hour giddines 
16 
referred to for 
arf 
78 
may 
23 
F perambalur housewife no 
right 
ankle 9:25 PM unidentified no 
pain 
8 
local no 
no 
no no 
nil 
absconded 
79 
may 
37 
F perambalur labourer no left foot 
10:50 
AM unidentified no 
pain 
7 
local no 
no 
no no 
nil 
recovered 
80 
june 
43 
M ariyalur watchman yes 
left 
middle 
finger 
11:20 
PM unidentified yes 
giddiness, 
ptosis 
8 
neurotoxic yes 
B.E A1602116 
1hr 
yes,itchin
g 
5 
recovered 
81 
may 
40 
M perambalur labourer no 
left 
lower 
limb 2:53 PM unidentified no 
pain 
8 
local no 
no 
no no 
nil 
recovered 
82 
may 
65 
M perambalur labourer no 
right big 
toe 3:00 PM unidentified no 
pain 
9 
local no 
no 
no no 
nil 
recovered 
83 
may 
40 
M perambalur labourer yes  left arm 
6:50 
AM unidentified no 
pain 
>20 
haemotoxic  yes 
bio vins 
01AS15040 
1hr no 
8 
recovered 
84 
may 
35 
M perambalur labourer no 
left big 
toe 8:00 PM unidentified no 
pain 
9 
local no 
nil 
no no 
nil 
recovered 
85 
may 
69 
M perambalur security no left foot 
8:50 PM unidentified no 
pain 
6 
local no 
nil 
no no 
nil 
recovered 
86 
may 
60 
M perambalur labourer yes left leg 
6:30 PM unidentified yes 
pain, 
swelling, 
oliguria >20 
haemotoxic  yes bio vins 
01AS15040 
1hr 
yes, 
persistent 
vomiting 13 
arf, referred to 
higher center 
87 
may 
40 
F perambalur labourer no right leg 
11:45 
AM unidentified no 
pain 
8 
local no 
nil 
no no 
nil 
recovered 
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88 
may 
60 
F perambalur labourer no 
right 
ankle 
11:05 
AM unidentified no 
pain 
10 
local no 
nil 
no no 
nil 
recovered 
89 
may 
35 
F perambalur labourer no 
right 
index 
finger 8:50 PM unidentified no 
pain 
11 
local no 
nil 
no no 
nil 
absconded 
90 
may 
51 
F perambalur labourer no 
left 
thumb 
12:40 
PM unidentified no 
pain 
11 
local no 
nil 
no no 
nil 
recovered 
91 
may 
8 
M perambalur student yes left leg 
11:00 
AM unidentified no 
pain 
>20 
haemotoxic  yes 
bio vins 
01AS15040 
1hr no 
13 
recovered 
92 
may 
23 
F perambalur student yes 
right 
arm 4:00 PM unidentified no 
pain 
>20 
haemotoxic  yes 
bio vins 
01AS15040 
1hr no 
23 
recovered 
93 may 21 M perambalur student no left leg 6:00 PM unidentified no pain 6 local no nil no no nil recovered 
94 
may 
32 
F ariyalur housewife no left leg 
8:00 PM unidentified no 
pain 
>20 
local yes 
B.E A1602116 
1hr no 
8 
recovered 
95 
may 
25 
M perambalur labourer yes 
right 
forearm 3:00 PM unidentified yes 
pain 
12 
local yes 
bio vins 
01AS15040 
1hr no 
8 
recovered 
96 
may 
38 
M erode driver yes 
right 
thumb 
finger  
11:30 
AM unidentified no 
swelling 
/blisters  
>20 
haemotoxic  yes Bharat 
sr.212008 
2hrs no 
14 
recovered  
97 
may 
18 
M perambalur labourer no 
left 
lower 
limb 
7:00 
AM unidentified yes 
dyspnea, 
drowsines
s, 
dysphagia 8 
neurotoxic yes 
bio vins 
01AS15040 
2hrs no 
18 
recovered 
98 
may 
5 
M perambalur student yes 
right 
hand 
11:00 
PM unidentified no 
pain 
>20 
haemotoxic  yes 
bio vins 
01AS15040 
1hr no 
13 
recovered 
99 
may 
35 
F perambalur labourer yes 
right 
foot 6:30 PM unidentified no 
cellulitis 
>20 
haemotoxic  yes 
bio vins 
01AS15040 
1hr no 
16 
recovered 
100 
may 
38 
M perambalur labourer no left foot 
11:07 
AM unidentified no 
pain 
6 
local no 
nil 
no no 
nil 
recovered 
101 
may 
29 
F perambalur housewife no left foot 
11:45 
PM unidentified no 
pain 
7 
local no 
nil 
no no 
nil 
recovered 
102 
may 
37 
M erode labourer yes  left hand 
2:30 PM unidentified no 
pain, 
swelling >20 
haemotoxic yes 
Bharat 
sr.31003 
6hrs no 
1 
recovered  
103 
may 
10 
M perambalur student no 
left big 
toe 3:00 PM unidentified no 
pain 
5 
local no 
nil 
no no 
nil 
absconded 
104 
may 
10 
M perambalur student no 
right 
ankle 3:00 PM unidentified no 
pain 
6 
local no 
nil 
no no 
nil 
absconded 
105 
may 
40 
F perambalur labourer yes right leg  
8:10 PM unidentified no 
pain 
>20 
haemotoxic  yes 
bio vins 
01AS15040 
1hr no 
5 
recovered 
106 
may 
36 
F perambalur labourer no right leg 
7:00 
AM unidentified no 
pain 
5 
local no 
nil 
no no 
nil 
absconded 
107 
may 
40 
M ariyalur farmer yes 
left 
thumb 
10.40 
PM  unidentified no 
pain 
>20 
haemotoxic  yes 
B.E A1602116 
2hrs no 
nil 
recovered  
108 
may 
24 
M perambalur labourer yes left leg 
7:35 
AM unidentified no 
cellulitis 
>20 
haemotoxic  yes 
bio vins 
01AS15040 
1hr giddines 
27 
recovered 
109 
may 
70 
F erode labourer yes  
right 
index 
finger 
10:30 
AM unidentified no 
swelling  
>20 
local yes Bharat 
sr.O12040 
2hrs itching 
11 
recovered  
110 
may 
28 
F perambalur housewife no 
right 
index 
finger 9:20 PM unidentified no 
pain 
7 
local no 
nil 
no no 
nil 
recovered 
111 
jun 
54 
M erode labourer yes  right leg  
11:30 
AM unidentified no 
swelling 
>20 
local yes 
Bharat 
sr.4053140 
7 hours  no 
3 
recovered  
112 
jun 
27 
M perambalur labourer no 
left 
lower 
limb 
11:50 
PM unidentified no 
pain 
5 
local no 
nil 
no no 
nil 
recovered 
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113 
jun 
34 
M perambalur labourer no 
right 
ankle 
10:50 
AM unidentified no 
pain 
7 
local no 
nil 
no no 
nil 
recovered 
114 
jun 
60 
F ariyalur farmer 
  
left foot 
12.05 
AM unidentified no 
drowsines
s, ptosis >20 
haemotoxic/ne
urotoxic 
yes 
bio vins 
01AS15040 
2hrs no 
13 
recovered  
115 
jun 
3 
M perambalur nil no 
left 
thumb 1:00 PM unidentified no 
pain 
5 
local no 
nil 
no no 
nil 
recovered 
116 
jun 
52 
F perambalur labourer no 
left 
ankle 9:00 PM unidentified no 
drowsines
s, ptosis 7 
neurotoxic yes 
bio vins 
01AS15040 
45 mins  no 
25 
recovered 
117 
jun 
63 
M perambalur security no 
right big 
toe 
12:00 
AM unidentified no 
pain 
11 
local no 
nil 
no no 
nil 
recovered 
118 
jun 
40 
M perambalur labourer no left foot 
11:40 
AM unidentified no 
pain 
12 
local no 
nil 
no no 
nil 
recovered 
119 
jun 
33 
M perambalur labourer no 
left 
forearm 1:30 PM unidentified no 
pain 
13 
local no 
nil 
no no 
nil 
recovered 
120 
jun 
38 
F perambalur labourer no 
right 4th 
toe 3:31 PM unidentified yes 
pain, 
giddiness 5 
neurotoxic yes 
bio vins 
01AS15040 
1hr no 
26 
absconded 
121 jun 55 M perambalur labourer no right leg 7:00 PM unidentified no pain 6 local no nil no no nil recovered 
122 
jun 
30 
M perambalur labourer no 
left 
lower 
limb 12:50 unidentified no 
drowsines
s, ptosis 
7 
neurotoxic yes bio vins 
01AS15040 
45 mins  no 
18 
recovered 
123 
jun 
26 
M perambalur labourer no 
right 
index 
finger 
10:30 
AM unidentified no 
pain 
5 
local no 
nil 
no no 
nil 
recovered 
124 jun 65 M perambalur labourer no left foot 2:50 PM unidentified no pain 7 local no nil no no nil recovered 
125 jun 65 M perambalur security no left foot 2:50 PM unidentified yes pain 11 local no nil no no nil recovered 
126 
jun 
26 
M perambalur labourer no 
left 
thumb 9:30 PM unidentified no 
pain 
12 
local no 
nil 
no no 
nil 
recovered 
127 
jun 
43 
F perambalur labourer no 
right 
ankle 3:00 
AM unidentified no 
pain, 
dyspnea, 
ophthalm
oplegia >20 
haemotoxic/ne
urotoxic 
yes 
bio vins 
01AS15040 
no no 
16 
absconded 
128 
jun 
22 
F perambalur housewife no 
left big 
toe 4:00 PM unidentified no 
pain 
5 
local no 
nil 
no no 
nil 
absconded 
129 
jun 
4 
M perambalur nil no left foot 
7:18 PM unidentified no 
pain 
6 
local no 
nil 
no no 
nil 
absconded 
130 
jun 
26 
M perambalur labourer yes 
right 
foot 
8:00 PM unidentified no 
pain, 
ptosis, 
giddiness 7 
neurotoxic yes bio vins 
01AS15040 
1hr no 
18 
recovered 
131 
jun 
20 
M perambalur student no 
left 
ankle 9:08 PM unidentified no 
pain 
5 
local no 
nil 
no no 
nil 
recovered 
132 
jun 
45 
M perambalur labourer no left foot 
6:00 PM unidentified no 
pain 
7 
local no 
nil 
no no 
nil 
recovered 
133 
jun 
60 
F perambalur labourer no left foot 
11:15 
PM unidentified no 
pain 
11 
local no 
nil 
no no 
nil 
recovered 
134 
jun 
70 
M perambalur labourer no 
left 
lower 
limb 11:55 
PM unidentified yes 
difficulty 
in 
breathing, 
, 
giddiness 12 
neurotoxic yes 
bio vins 
01AS15040 
1hr no 
24 
death due to 
respiratory 
failure 
135 
jun 
24 
M ariyalur farmer no left foot 
9:40 
AM unidentified yes 
pain 
13 
local no 
nil 
no no 
nil 
recovered  
136 
jun 
26 
M perambalur labourer no left foot 
10:20 
AM unidentified no 
pain 
5 
local no 
nil 
no no 
nil 
recovered 
137 jun 65 M perambalur labourer no left foot 11:00 unidentified no pain 6 local no nil no no 16 recovered 
 
 
119 
 
AM 
138 
jun 
70 
M ariyalur farmer no left foot 
8.20 
AM unidentified no 
ptosis, 
dysphagia 7 
neurotoxic yes 
bio vins 
01AS15040 
2hrs no 
nil 
absconded 
139 
jun 
54 
F perambalur labourer no 
right 
ankle 8:40 PM unidentified no 
pain 
5 
local no 
nil 
no no 
nil 
absconded 
140 
jun 
25 
M perambalur labourer no 
left big 
toe 6:00 PM unidentified no 
pain 
7 
local no 
nil 
no no 
nil 
recovered 
141 
jun 
22 
F perambalur housewife no right leg 
7:00 
AM unidentified no 
pain 
11 
local no 
nil 
no no 
nil 
absconded 
142 
jun 
4 
M perambalur nil no 
right big 
toe 8:40 PM unidentified no 
pain 
12 
local no 
nil 
no no 
nil 
absconded 
143 
jun 
26 
M perambalur labourer no 
right 
ankle 
8:55 
AM unidentified no 
pain 
13 
local no 
nil 
no no 
nil 
recovered 
144 
jun 
16 
M perambalur student no 
left 
thumb 7:00 
AM unidentified no 
pain, 
swelling, 
lymphade
nopathy >20 
haemotoxic yes 
bio vins 
01AS15040 
20 mins no 
13 
recovered 
145 jun 20 M perambalur labourer no left foot 6:00 PM unidentified no pain 7 local no nil no no nil recovered 
146 
jun 
37 
M perambalur labourer no 
right 
ankle 6:30 PM unidentified no 
pain 
9 
local no 
nil 
no no 
nil 
recovered 
147 
jun 
60 
F perambalur labourer no 
left 
lower 
limb 6:30 PM unidentified no 
pain 
10 
local no 
nil 
no no 
nil 
recovered 
148 
jun 
70 
M perambalur labourer no left foot 
7:00 
AM unidentified no 
pain 
7 
local no 
nil 
no no 
nil 
recovered 
149 
jun 
23 
F perambalur housewife no left foot 
6:00 PM unidentified no 
pain, 
drowsines
s, 
dysphagia 6 
neurotoxic yes 
bio vins 
01AS15040 
45 mins  
yes. 
nausea, 
vomiting 
8 
recovered 
150 
jun 
13 
M perambalur student no 
right 
ankle 8:00 PM unidentified yes 
pain 
11 
local no 
nil 
no no 
nil 
recovered 
151 
jun 
32 
M perambalur labourer yes left leg 
8:00 PM unidentified no 
pain 
>20 
haemotoxic yes 
bio vins 
01AS15040 
1hr no 
nil 
recovered 
152 
jun 
70 
M perambalur labourer no 
right big 
toe 8:00 PM unidentified no 
pain 
7 
local no 
nil 
no no 
nil 
recovered 
153 
jun 
45 
F perambalur labourer no 
left big 
toe 
8:40 PM unidentified no 
difficulty 
in 
breathing, 
, 
giddiness 8 
neurotoxic yes 
bio vins 
01AS15040 
no no 
nil 
recovered 
154 
jun 
13 
M perambalur student no 
right 
ankle 
11:00 
PM unidentified yes 
pain 
11 
local no 
nil 
no no 
nil 
recovered 
155 
jun 
70 
F perambalur labourer no 
right 
ankle 6:00 PM unidentified no 
pain 
12 
local no 
nil 
no no 
nil 
recovered 
156 
jun 
23 
M perambalur labourer yes 
right 
foot 4:00 PM R.viper yes 
cellulitis 
>20 
haemotoxic  yes 
B.E A1602116 
1hr 
chills & 
rigor 13 
recovered 
157 
jul 
40 
M erode labourer yes  left leg  
2.30 PM  unidentified no 
swelling 
/blisters  >20 
haemotoxic  yes 
Bharat 
sr.4053140 
1hr itching 
6 
recovered  
158 
jul 
23 
F perambalur housewife no 
right 
ankle 8:00 PM unidentified no 
pain 
7 
local no 
nil 
no no 
nil 
recovered 
159 
jul 
55 
M perambalur labourer no 
right 
index 
finger 9:00 PM unidentified no 
pain 
11 
local no 
nil 
no no 
nil 
recovered 
160 
jul 
23 
M perambalur labourer no 
left 
forearm 6:00 PM unidentified no 
pain 
6 
local no 
nil 
no no 
nil 
recovered 
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161 
jul 
60 
M perambalur labourer no left foot 
3:00 
AM unidentified no 
pain 
7 
local no 
nil 
no no 
nil 
recovered 
162 
jul 
55 
M perambalur labourer yes left leg 
7:00 
AM unidentified no 
cellulitis 
>20 
haemotoxic  yes 
bio vins 
01AS15040 
1hr no 
13 
recovered 
163 
jul 
62 
M perambalur labourer yes 
right 
foot 
10:00 
AM unidentified no 
pain 
>20 
haemotoxic  yes 
bio vins 
01AS15040 
1hr no 
28 
recovered 
164 
jul 
34 
M ariyalur labourer no 
left 
lower 
limb 
11.00 
AM  unidentified no 
pain 
11 
local no 
nil 
no no 
nil 
absconded 
165 
jul 
75 
M ariyalur farmer yes 
right 
forearm 
7.30 
AM unidentified no 
pain,oligu
ria >20 
haemotoxic yes 
B.E A1602116 
40 mins no 
8 
referred to 
trichy  
166 
jul 
65 
F ariyalur farmer yes 
left big 
toe 
7.20 
AM unidentified yes 
pain 
10 
local yes 
B.E A1602116 
30 mins no 
8 
recovered  
167 
jul 
40 
F ariyalur farmer yes 
right 
ankle 1.10 PM unidentified no 
pain 
8 
local no 
nil 
no no 
nil 
referred to 
trichy  
168 
jul 
65 
M ariyalur labourer no 
right 
ankle 
11:55 
AM unidentified no 
pain 
9 
local no 
nil 
no no 
nil 
recovered  
169 
jul 
70 
M perambalur labourer no 
left big 
toe 
0:00 
AM/PM unidentified no 
pain 
12 
local no 
nil 
no no 
nil 
recovered 
170 
jul 
40 
M perambalur labourer yes 
left 
middle 
finger 
10:00 
AM unidentified no 
pain, 
thromboc
ystopenia 
>20 
haemotoxic  yes 
bio vins 
01AS15040 
1hr no 
28 
recovered, 
2platelets 
packed cell 
transfusion 
171 
jul 
18 
F perambalur housewife no 
left big 
toe 7:15 PM unidentified no 
pain 
8 
local no 
nil 
no no 
nil 
discharged at 
request 
172 jul 84 M perambalur labourer no right leg 2:45 PM unidentified no pain 9 local no nil no no nil recovered 
173 
jul 
49 
M perambalur labourer no 
left 
thumb 7:50 PM unidentified no 
pain 
12 
local no 
nil 
no no 
nil 
recovered 
174 
jul 
57 
M perambalur labourer yes right leg  
10:00 
AM unidentified no 
cellulitis 
>20 
haemotoxic  yes 
bio vins 
01AS15040 
1hr no 
30 
recovered 
175 
jul 
45 
F perambalur labourer no 
left 
ankle 
7:00 
AM unidentified no 
pain 
11 
local no 
nil 
no no 
nil 
recovered 
176 
jul 
35 
M perambalur labourer no left foot 
7:00 
AM unidentified no 
pain 
10 
local no 
nil 
no no 
nil 
absconded 
177 
jul 
20 
M ariyalur labourer yes left foot 
4.50 PM unidentified no 
pain 
8 
local no 
nil 
no no 
nil 
ama 
178 
jul 
30 
F perambalur labourer no 
right 
index 
finger 
10:30 
PM unidentified no 
pain 
9 
local no 
nil 
no no 
nil 
recovered 
179 
jul 
50 
M perambalur labourer no 
left 
lower 
limb 8:55 PM unidentified no 
pain 
12 
local no 
nil 
no no 
nil 
recovered 
180 
jul 
50 
M perambalur labourer no 
right 
ankle 5:30 PM unidentified no 
pain 
11 
local no 
nil 
no no 
nil 
recovered 
181 
jul 
47 
F perambalur labourer no 
right 
foot 7:45 PM unidentified no 
pain 
8 
local no 
nil 
no no 
nil 
recovered 
182 
jul 
43 
F perambalur labourer no left foot 
3:30 PM unidentified no 
pain 
9 
local no 
nil 
no no 
nil 
recovered 
183 
jul 
35 
F perambalur labourer no 
right 
foot 7:15 PM unidentified no 
pain 
11 
local no 
nil 
no no 
nil 
recovered 
184 
jul 
30 
M erode labourer yes  left hand  
10:00 
AM unidentified no 
pain, 
swelling >20 
haemotoxic  yes 
Bharat 
sr.31003 
3hrs no 
8 
recovered  
185 
jul 
55 
F perambalur labourer no 
right 
foot 
7:00 
AM unidentified no 
pain, 
swelling 11 
local no 
no 
no no 
nil 
absconded 
186 
jul 
55 
M perambalur labourer no left foot 
0:00 
AM/PM unidentified no 
pain 
10 
local no 
no 
no no 
nil 
recovered 
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187 
jul 
34 
M erode tailor  yes  right leg  
2:00 PM unidentified no 
pain 
>20 
haemotoxic  yes 
Bharat 
sr.31003 
30 mins no 
16 
recovered  
188 
jul 
40 
F perambalur labourer yes right leg  
8:00 PM unidentified yes 
cellulitis 
>20 
haemotoxic  yes 
Biological E 
limited 
A1602116 
1hr no 
13 
recovered 
189 
jul 
32 
M perambalur labourer yes left leg 
7:45 PM unidentified yes 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
A1602116 
1hr no 
15 
recovered 
190 
jul 
59 
M perambalur labourer no 
left 
lower 
limb 8:55 PM unidentified no 
pain 
8 
local no 
nil 
no no 
nil 
recovered 
191 
jul 
32 
M perambalur labourer no 
right big 
toe 5:30 PM unidentified no 
pain 
9 
local no 
nil 
no no 
nil 
recovered 
192 
jul 
27 
F perambalur labourer no 
left 
ankle 6:00 PM unidentified no 
pain 
7 
local no 
nil 
no no 
nil 
recovered 
193 
jul 
57 
F perambalur labourer no 
left 
thumb 8:40 PM unidentified no 
pain 
8 
local no 
nil 
no no 
nil 
recovered 
194 
jul 
35 
F perambalur labourer no left foot 
7:00 
AM unidentified yes 
pain 
8 
local no 
nil 
no no 
nil 
recovered 
195 
jul 
43 
F perambalur labourer no 
right 
ankle 6:00 PM unidentified no 
pain 
12 
local no 
nil 
no no 
nil 
recovered 
196 
jul 
42 
F perambalur labourer no left foot 
7:00 
AM unidentified no 
pain 
11 
local no 
nil 
no no 
nil 
recovered 
197 jul 50 M perambalur labourer no left foot 8:55 PM unidentified no pain 11 local no nil no no nil recovered 
198 
jul 
30 
F perambalur labourer no 
right 
foot 8:40 PM unidentified no 
pain 
8 
local no 
nil 
no no 
nil 
recovered 
199 
jul 
40 
F perambalur labourer yes left foot 
8:55 PM unidentified no 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
A1602116 
1hr no 
13 
recovered 
200 
aug 
60 
F ariyalur farmer yes 
left 
lower 
limb 1.10 PM unidentified no 
pain 
8 
local no 
nil 
no no 
nil 
recovered  
201 
aug 
40 
F perambalur labourer yes 
left 
forearm 
5:00 PM unidentified no 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
A1602116 
1hr no 
13 
recovered 
202 
aug 
40 
M perambalur labourer yes left foot 12:40 
PM unidentified no 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
A1602116 
1hr no 
5 
recovered 
203 
aug 
40 
M perambalur labourer no left foot 
7:00 
AM unidentified no 
pain 
9 
local no 
nil 
no no 
nil 
recovered 
204 
aug 
75 
F ariyalur labourer no left foot 
8.30 PM unidentified no 
pain 
8 
local no 
nil 
no no 
nil 
recovered  
205 
aug 
46 
M ariyalur labourer no 
right 
ankle 
9.00 
AM  unidentified no 
pain 
11 
local no 
nil 
no no 
nil 
recovered  
206 
aug 
83 
M perambalur labourer no 
right 
foot 
7:00 
AM unidentified no 
pain 
12 
local no 
nil 
no no 
nil 
recovered 
207 
aug 
65 
M perambalur labourer yes 
left 
thumb 
7:20 
AM unidentified no 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
A1602116 
1hr no 
18 
recovered 
208 
aug 
29 
M perambalur labourer no left foot 
8:40 PM unidentified no 
pain 
9 
local no 
nil 
no no 
nil 
recovered 
209 
aug 
40 
F perambalur labourer no 
left big 
toe 7:15 PM unidentified no 
pain 
10 
local no 
nil 
no no 
nil 
recovered 
210 
aug 
45 
M perambalur labourer yes 
right 4 
th finger  
2:45 PM unidentified no 
drowsines
s,ptosis,s
welling >20 
haemotoxic/ne
urotoxic  
yes 
Biological E 
limited 
A1602116 
1hr no 
13 
recovered 
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211 
aug 
45 
F perambalur labourer yes left leg 10:30 
PM unidentified no 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
A1602116 
1hr no 
16 
recovered 
212 
aug 
17 
F perambalur student yes 
right 
index 
finger 
7:50 PM unidentified no 
respirator
y distress, 
poor gcs, 
intubated 8 
neurotoxic yes 
Biological E 
limited 
A1602116 
1hr no 
8 
respiratory 
failure, referred 
to highr center 
213 
aug 
35 
M perambalur labourer no left leg 
7:15 PM unidentified no 
pain 
11 
local no 
nil 
no no 
nil 
recovered 
214 
aug 
50 
M perambalur labourer no 
right 
ankle 2:45 PM unidentified no 
pain 
8 
local no 
nil 
no no 
nil 
recovered 
215 
aug 
13 
M perambalur labourer no 
left 
lower 
limb 7:50 PM unidentified no 
pain 
9 
local no 
nil 
no no 
nil 
recovered 
216 
aug 
40 
M erode labourer yes  left hand 
11:00 
AM unidentified no 
swelling 
/blisters  >20 
haemotoxic yes 
Bharat 
sr.4053140 
1hr no 
5 
recovered  
217 
aug 
50 
F erode labourer yes 
left 
middle 
finger 6:15 PM unidentified no 
swelling 
/blisters  
>20 
haemotoxic yes Bharat 
sr.O12040 
3hrs itching 
8 
recovered  
218 
aug 
17 
M perambalur student no 
right big 
toe 7:15 PM unidentified no 
pain 
10 
local no 
nil 
no no 
nil 
absconded 
219 
aug 
50 
F perambalur labourer no left foot 
2:45 PM unidentified no 
pain 
11 
local no 
nil 
no no 
nil 
recovered 
220 
aug 
50 
F perambalur labourer no 
right 
ankle 7:50 PM unidentified no 
pain 
12 
local no 
nil 
no no 
nil 
recovered 
221 
aug 
80 
M ariyalur labourer yes 
right 
forearm 
11.45 
AM unidentified no 
pain 
8 
local no 
nil 
no no 
nil 
recovered  
222 
aug 
7 
F ariyalur student  no left foot 
9.00 PM unidentified yes 
pain, 
ptosis, 
giddiness 9 
neurotoxic no 
Biological E 
limited 
A1602116 
30 mins no 
16 
recovered  
223 
aug 
18 
M ariyalur student  no 
right 
foot 
7.10 
AM unidentified no 
pain 
9 
local no 
nil 
no no 
nil 
recovered  
224 
aug 
29 
F perambalur labourer no 
right 4th 
toe 6:00 PM unidentified no 
pain 
11 
local no 
nil 
no no 
nil 
recovered 
225 
aug 
35 
F perambalur labourer no left foot 
12:40 
PM unidentified no 
pain 
10 
local no 
nil 
no no 
nil 
absconded 
226 
aug 
50 
M perambalur labourer yes left foot 
2:25 PM unidentified yes 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
A1602116 
1hr no 
13 
recovered 
227 
aug 
24 
M ariyalur student  no 
right 
foot 
11.OO 
PM unidentified no 
pain 
9 
local no 
nil 
no no 
nil 
recovered  
228 
aug 
34 
F ariyalur farmer yes 
right 
ankle 
12:40 
PM unidentified no 
pain 
11 
local no 
nil 
no no 
nil 
recovered  
229 
aug 
55 
F perambalur labourer yes right leg  
7:45 PM unidentified no 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
A1602116 
1hr no 
23 
recovered 
230 
aug 
37 
F perambalur labourer yes left leg 
3:30 PM unidentified no 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
A1602116 
1hr no 
8 
recovered 
231 
aug 
37 
F perambalur labourer no 
left 
lower 
limb 6:00 PM unidentified no 
pain 
14 
local no 
nil 
no no 
nil 
recovered 
232 
aug 
42 
M perambalur labourer no 
right 
ankle 
7:00 
AM unidentified no 
pain 
13 
local no 
nil 
no no 
nil 
recovered 
233 
aug 
38 
M ariyalur farmer no left foot 
6.00 
AM unidentified no 
pain 
11 
local no 
nil 
no no 
nil 
recovered  
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234 
aug 
52 
M perambalur labourer no right leg 
12.22 
PM unidentified no 
pain 
8 
local no 
nil 
no no 
nil 
recovered 
235 
aug 
3 
F perambalur nil no 
right 
foot 1.56 PM unidentified no 
pain 
9 
local no 
nil 
no no 
nil 
recovered 
236 
aug 
20 
M perambalur student yes right leg  
1:00 PM unidentified no 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
A1602116 
1hr no 
13 
recovered 
237 
aug 
28 
F erode housewife yes  
left little 
finger 2:00 PM unidentified no 
swelling 
/blisters  >20 
haemotoxic  yes 
Bharat 
sr.O12040 
30 mins no 
10 
recovered  
238 
aug 
19 
F perambalur student no 
right 
index 
finger 
11.20 
AM unidentified no 
pain 
8 
local no 
nil 
no no 
nil 
recovered 
239 
aug 
55 
M ariyalur farmer yes 
right 
ankle 
1.30 
AM unidentified no 
cellulitis 
9 
local no 
nil 
no no 
nil 
recovered  
240 
aug 
43 
M perambalur labourer no 
left 
lower 
limb 6:50 PM unidentified no 
pain 
10 
local no 
nil 
no no 
nil 
recovered 
241 aug 20 M perambalur student no left foot 8:40 PM unidentified no pain 11 local no nil no no nil recovered 
242 
aug 
53 
F perambalur labourer no 
left 
forearm 
6:00 PM unidentified no 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
A1602116 
1hr no 
20 
recovered 
243 
aug 
75 
F perambalur labourer yes 
left 
middle 
finger 7:45 PM unidentified no 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
A1602116 
1hr no 
8 
recovered 
244 
aug 
59 
M perambalur labourer yes left leg 
3:30 PM unidentified yes 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
A1602116 
1hr no 
10 
recovered 
245 
aug 
75 
F ariyalur labourer yes 
right 
forearm 
12.05 
PM  unidentified no 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
A1602116 
2hrs no 
8 
recovered 
246 aug 35 F ariyalur farmer yes left foot 8:40 PM unidentified no pain 8 local no nil no no nil recovered  
247 
aug 
25 
M perambalur labourer no 
left big 
toe 6:00 PM unidentified no 
pain 
9 
local no 
nil 
no no 
nil 
absconded 
248 
aug 
25 
M ariyalur student  yes 
left 
ankle 
12.22 
PM unidentified yes 
pain 
11 
local no 
nil 
no no 
nil 
absconded 
249 
aug 
50 
M ariyalur farmer yes right leg 
1.56 PM unidentified no 
pain 
10 
local no 
nil 
no no 
nil 
recovered  
250 
aug 
48 
M perambalur labourer no left foot 
8:40 PM unidentified no 
pain 
8 
local no 
nil 
no no 
nil 
recovered 
251 
aug 
75 
M perambalur labourer no 
left 
thumb 
11.20 
AM unidentified no 
pain 
9 
local no 
nil 
no no 
nil 
recovered 
252 
aug 
28 
M erode labourer yes  left leg  
5:00 PM unidentified no 
pain, 
swelling >20 
haemotoxic  yes 
Bharat 
sr.Q50531003 
3hrs itching 
6 
recovered  
253 
aug 
36 
F ariyalur labourer no right leg 
10.30 
PM unidentified no 
pain 
11 
local no 
nil 
no no 
nil 
recovered  
254 
aug 
70 
M ariyalur farmer yes 
right 
foot 
3.10 
AM unidentified yes 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
A1602116 30 mins 
no 
8 
recovered  
255 
aug 
68 
F ariyalur farmer yes 
right 
lower 
limb 7.05 PM unidentified no 
pain, 
swelling 
>20 
haemotoxic  yes 
Biological E 
limited 
A1602116 
1hr no 
18 
2pffp given  
256 
aug 
45 
M ariyalur farmer no left foot 
1.35 PM unidentified no 
pain 
8 
local no 
nil 
no no 
nil 
recovered  
257 
aug 
75 
M ariyalur farmer no 
left 
forearm 3.10 PM unidentified no 
pain 
10 
local no 
nil 
no no 
nil 
recovered  
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258 
aug 
68 
F perambalur labourer yes right leg  
7:45 PM unidentified yes 
swelling 
/blisters  
>20 
haemotoxic  yes 
Biological E 
limited 
A1602116 
1hr no 
18 
recovered, 2p 
packed cell & 
2p ffp 
259 
aug 
70 
M perambalur labourer yes 
right 
foot 
3:30 PM unidentified no 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
A1602116 
1hr no 
8 
recovered 
260 
aug 
40 
M ariyalur farmer no left foot 
4.15 PM unidentified no 
pain 
9 
local yes 
Biological E 
limited 
A1602117 
45 mins  no 
8 
recovered  
261 
aug 
60 
M perambalur labourer yes left leg 
4:10 PM unidentified no 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
A1602116 
1hr no 
8 
recovered 
262 
sep 
27 
F perambalur housewife yes 
right 
foot  
11.20 
AM 
identified 
(russels viper) no 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
A1602116 
1hr 
anaphylax
is  
18 
recovered 
263 
sep 
40 
F perambalur labourer no 
right 
ankle 8:40 PM unidentified no 
pain 
7 
local no 
nil 
no no 
nil 
recovered 
264 
sep 
40 
F perambalur labourer yes 
right big 
toe 1.30 
AM unidentified no 
dyspnea, 
drowsines
s, 
dysphagia >20 
neurotoxic yes 
Biological E 
limited 
A1602116 
1hr no 
20 
singl
e 
dose 
referred to 
higher centre 
265 
sep 
40 
F ariyalur farmer yes 
right 
foot 
4.00 PM unidentified yes 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
A1602116 
30 mins no 
20 
recovered  
266 
sep 
42 
F perambalur labourer no 
right 
ankle 5:30 PM unidentified no 
pain 
11 
local no 
nil 
no no 
nil 
recovered 
267 sep 15 M perambalur student no left foot 6:00 PM unidentified no pain 12 local no nil no no nil recovered 
268 
sep 
31 
M ariyalur labourer yes 
right 
ankle 
10.50 
PM unidentified no 
pain 
11 
local no 
nil 
no no 
nil 
recovered  
269 
sep 
38 
F erode labourer yes  right leg  
10:00 
AM unidentified no 
drowsines
s/bleeding
/haematur
ia >20 
haemotoxic/ne
urotoxic  
yes 
Bharat 
sr.4053140 
1hr giddines 
10 
recovered  
270 
sep 
40 
F erode labourer no 
unknow
n  
4:00 
AM unidentified no 
nil 
10 
local yes 
Bharat 
sr.4053140 
8hrs no 
2 
recovered  
271 
sep 
40 
M erode driver yes  
right 
hand  2.40 PM unidentified no 
pain, 
swelling 9 
local yes 
Bharat 
sr.4053140 
3hrs no 
2 
recovered  
272 
sep 
65 
M perambalur labourer no 
left 
lower 
limb 3:35 PM unidentified no 
pain 
5 
local no 
nil 
no no 
nil 
recovered 
273 sep 52 F perambalur labourer no right leg 6:00 PM unidentified no pain 9 local no nil no no nil recovered 
274 
sep 
40 
F perambalur labourer no left foot 
11.20 
AM unidentified no 
pain 
11 
local no 
nil 
no no 
nil 
recovered 
275 
sep 
12 
F perambalur student no 
left big 
toe 
8:40 PM unidentified no 
ptosis,dys
pnea 
12 
neurotoxic no 
Biological E 
limited 
A1602116 
25 mins no 
18 
recovered 
276 
sep 
40 
F perambalur labourer no 
right 
foot 5:45 PM unidentified no 
pain 
5 
local no 
nil 
no no 
nil 
recovered 
277 
sep 
27 
F ariyalur student  yes 
right 
index 
finger 8.45 PM unidentified no 
pain 
11 
local no 
nil 
no no 
nil 
dis at request  
278 
sep 
18 
M perambalur labourer no left foot 
2:00 PM unidentified no 
pain 
9 
local no 
nil 
no no 
nil 
recovered 
279 
sep 
52 
M perambalur labourer yes 
right 
foot  
7:00 
AM unidentified no 
pain 
>20 
haemotoxic  yes 
Bharat 
sr.Q52421200
1hr 
fever, 
chills & 10 
recovered 
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7 rigor 
280 
sep 
37 
M perambalur labourer yes left leg 11.20 
AM unidentified no 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
A1602116 
1hr no 
8 
recovered 
281 
sep 
50 
M perambalur labourer yes left leg 
8:00 PM unidentified no 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
A1602116 
1hr no 
16 
recovered 
282 
sep 
50 
M perambalur labourer yes 
right 
ankle 
7:45 PM unidentified no 
dyspnea, 
drowsines
s, 
dysphagia >20 
neurotoxic yes 
Biological E 
limited 
A1602116 
1hr no 
18 
recovered 
283 
sep 
35 
M perambalur labourer yes left foot 10:30 
PM unidentified yes 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
A1602116 
1hr no 
13 
recovered 
284 
sep 
33 
M perambalur labourer no 
left 
thumb 8:55 PM unidentified no 
pain 
11 
local no 
nil 
no no 
nil 
recovered 
285 
sep 
26 
F perambalur housewife no right leg 
5:30 PM unidentified yes 
pain 
10 
local no 
nil 
no no 
nil 
recovered 
286 
sep 
40 
F perambalur labourer no 
left 
ankle 2:00 PM unidentified no 
pain 
11 
local no 
nil 
no no 
nil 
recovered 
287 
sep 
47 
M perambalur labourer no 
right 
foot 
7:00 
AM unidentified no 
pain 
8 
local no 
nil 
no no 
nil 
recovered 
288 
sep 
50 
F ariyalur farmer yes 
right 
index 
finger 
10.20 
AM  unidentified no 
pain 
9 
local no 
nil 
no no 
nil 
recovered  
289 
sep 
45 
F erode farmer no 
unknow
n  
11.30 
AM unidentified no 
pain, 
swelling >20 
haemotoxic yes 
Bharat 
sr.O12040 
30 mins no 
11 
recovered  
290 
sep 
50 
M erode farmer yes  
right 
little 
finger 
11.40 
AM unidentified no 
pain, 
swelling 
>20 
haemotoxic  yes Bharat 
sr.O12040 
30 mins no 
5 
recovered  
291 
sep 
60 
M perambalur labourer no 
left 
lower 
limb 5:00 PM unidentified no 
pain 
11 
local no 
nil 
no no 
nil 
recovered 
292 
sep 
45 
F erode farmer yes  left foot  
12:45 
PM unidentified no 
swelling 
/blisters  6 
local yes 
Bharat 
sr.212008 
1hr itching 
16 
recovered  
293 
sep 
36 
M ariyalur farmer yes 
left 
thumb 
12.00. 
PM unidentified no 
pain 
8 
local no 
nil 
no no 
nil 
recovered  
294 
sep 
45 
M ariyalur labourer no left foot 
11.30 
AM unidentified no 
pain 
9 
local no 
nil 
no no 
nil 
recovered  
295 
sep 
28 
M erode labourer yes  left leg  
9.30 
AM  unidentified no 
pain, 
swelling 14 
local yes 
Bharat 
sr.O12039 
3hrs itching 
8 
recovered  
296 
sep 
12 
M perambalur labourer no 
right big 
toe 
11.20 
AM unidentified no 
pain 
14 
local no 
nil 
no no 
nil 
recovered 
297 
sep 
27 
M ariyalur farmer no 
right 2th 
toe 
2.35 
AM unidentified no 
pain 
15 
local no 
nil 
no no 
nil 
recovered  
298 
sep 
2 
F ariyalur nil yes 
right 
ankle 
10.00 
PM unidentified no 
pain 
12 
local no 
nil 
no no 
nil 
absconded 
299 
sep 
50 
M perambalur labourer no 
left 
ankle 7:45 PM unidentified no 
pain 
11 
local no 
nil 
no no 
nil 
recovered 
300 
sep 
35 
M perambalur labourer no 
right 
foot 3:30 PM unidentified yes 
pain 
10 
local no 
nil 
no no 
nil 
recovered 
301 
sep 
45 
M perambalur labourer yes left leg 
6:00 PM unidentified no 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
A1602116 
1hr no 
5 
discharged ama 
302 
sep 
40 
F ariyalur farmer yes 
left 
forearm 
11.20 
AM unidentified no 
pain 
11 
local no 
nil 
no no 
nil 
recovered  
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303 
sep 
60 
M perambalur labourer no 
left 
ankle 
10:30 
PM unidentified yes 
pain 
13 
local no 
nil 
no no 
nil 
recovered 
304 
sep 
60 
F perambalur labourer no 
left 
ankle 8:55 PM unidentified no 
pain 
11 
local no 
nil 
no no 
nil 
recovered 
305 sep 48 F ariyalur farmer no left foot 5:30 PM unidentified no pain 13 local no nil no no nil recovered  
306 
sep 
22 
M perambalur labourer no 
left 
thumb 7:45 PM unidentified no 
pain 
14 
local no 
nil 
no no 
nil 
recovered 
307 
sep 
12 
M perambalur student yes 
right 
foot  
3:30 PM unidentified no 
pain 
>20  
haemotoxic  yes 
Biological E 
limited 
A1602116 
1hr no 
13 
recovered 
308 
sep 
38 
M perambalur labourer yes 
right 4 
th finger  
7:15 PM unidentified no 
pain 
>20  
haemotoxic  yes 
Biological E 
limited 
A1602116 
1hr no 
18 
recovered 
309 
sep 
65 
F ariyalur farmer yes 
right 
hand  
12.40 
PM  unidentified no 
pain 
12 
local no 
nil 
no no 
nil 
recovered  
310 
sep 
38 
M perambalur labourer yes left leg 11.20 
AM unidentified no 
pain 
>20  
local yes 
Biological E 
limited 
A1602116 
1hr 
yes, 
itching 
24 
recovered 
311 
sep 
42 
F ariyalur farmer yes 
right 
ankle 5.15 PM unidentified no 
pain 
9 
local no 
nil 
no no 
nil 
referred to gh 
312 
sep 
50 
M perambalur labourer no left foot 
11.20 
AM unidentified no 
pain 
8 
local no 
nil 
no no 
nil 
recovered 
313 
sep 
40 
F ariyalur farmer yes 
right 
forearm 9.40 PM unidentified yes 
pain 
11 
local no 
nil 
no no 
nil 
recovered  
314 sep 33 M perambalur labourer no right leg 3:00 PM unidentified no pain 10 local no nil no no nil recovered 
315 
sep 
45 
F perambalur labourer yes 
right 
foot  
7:45 PM unidentified yes 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
A1602116 
1hr no 
13 
recovered 
316 
sep 
45 
F perambalur labourer yes 
right 
foot  
3:30 PM unidentified no 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
A1602116 
1hr no 
5 
recovered 
317 
sep 
33 
M perambalur labourer no 
right big 
toe 6:00 PM unidentified no 
pain 
10 
local no 
nil 
no no 
nil 
recovered 
318 
sep 
50 
F perambalur labourer no 
left 
thumb 7:15 PM unidentified no 
pain 
12 
local no 
nil 
no no 
nil 
recovered 
319 
sep 
35 
M perambalur labourer yes 
right 
index 
finger 2:45 PM unidentified yes 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
A1602116 
1hr no 
8 
recovered 
320 
sep 
19 
M perambalur labourer no 
right 
ankle 7:50 PM unidentified no 
pain 
8 
local no 
nil 
no no 
nil 
recovered 
321 
sep 
43 
M perambalur labourer no 
left 
lower 
limb 
7:00 
AM unidentified no 
pain 
9 
local no 
nil 
no no 
nil 
recovered 
322 sep 27 M perambalur labourer no left foot 6:00 PM unidentified no pain 11 local no nil no no nil recovered 
323 
sep 
59 
M perambalur labourer yes left foot 
6:00 PM unidentified no 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
A1602116 
1hr no 
13 
recovered 
324 
sep 
45 
M erode labourer yes right leg  
4:30 PM unidentified no 
pain, 
swelling >20 
local yes 
Bharat 
sr.31003 
4 hrs no 
3 
recovered  
325 
sep 
55 
F perambalur labourer no 
left 
ankle 7:15 PM unidentified no 
pain 
8 
local no 
nil 
no no 
nil 
recovered 
326 
sep 
55 
F perambalur labourer no 
left big 
toe 2:45 PM unidentified no 
pain 
7 
local no 
nil 
no no 
nil 
recovered 
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327 
sep 
49 
M perambalur labourer no left foot 
7:50 PM unidentified no 
pain 
9 
local no 
nil 
no no 
nil 
recovered 
328 
sep 
43 
M ariyalur labourer yes 
left 
ankle 3.00 PM unidentified no 
pain 
11 
local no 
nil 
no no 
nil 
recovered  
329 
sep 
27 
M perambalur labourer no 
right 
foot 2:45 PM unidentified no 
pain 
7 
local no 
nil 
no no 
nil 
recovered 
330 
sep 
51 
M perambalur labourer no 
right 2th 
toe 
7:00 
AM unidentified no 
pain 
8 
local no 
nil 
no no 
nil 
recovered 
331 
sep 
16 
M ariyalur farmer yes 
left 
forearm 
10.40 
PM  unidentified no 
pain 
9 
local no 
nil 
no no 
nil 
recovered  
332 
sep 
53 
M perambalur labourer yes left foot 
2:45 PM unidentified no 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
A1602116 
1hr no 
8 
recovered 
333 
sep 
23 
F perambalur student no right leg 
7:50 PM unidentified no 
pain 
8 
local no 
nil 
no no 
nil 
recovered 
334 
sep 
30 
F perambalur labourer no 
right 
ankle 3.00 PM unidentified yes 
pain 
9 
local no 
nil 
no no 
nil 
absconded 
335 
sep 
14 
M perambalur student yes 
left 
thumb 
10:30 
PM unidentified no 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
A1602116 
1hr no 
8 
recovered 
336 
sep 
60 
M perambalur labourer yes 
right 
index 
finger 8:55 PM unidentified no 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
A1602116 
1hr no 
8 
recovered 
337 
sep 
60 
M perambalur labourer yes left leg 
5:30 PM unidentified no 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
A1602116 
1hr no 
8 
recovered 
338 
sep 
40 
M perambalur labourer yes left leg 
7:45 PM unidentified no 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
A1602116 
1hr 
yes,itchin
g 
8 
recovered 
339 
sep 
10 
M perambalur labourer no 
right 
foot 3:30 PM unidentified no 
pain 
9 
local no 
nil 
no no 
nil 
absconded 
340 
sep 
23 
F perambalur housewife no 
right big 
toe 7:15 PM unidentified no 
pain 
10 
local no 
nil 
no no 
nil 
recovered 
341 
sep 
65 
M ariyalur farmer no 
left 
lower 
limb 8.45 PM unidentified no 
pain 
8 
local no 
nil 
no no 
nil 
recovered  
342 
sep 
45 
M ariyalur farmer yes 
left big 
toe 
11.20 
AM unidentified no 
drowsines
s, 
dysphagia 10 
neurotoxic yes 
Biological E 
limited 
A1602116 
45 mins  
yes, fever, 
chills& 
rigor 20 
recovered  
343 
sep 
11 
F ariyalur student yes left foot 
7.30 
AM  unidentified no 
pain 
10 
local no 
nil 
no no 
nil 
recovered  
344 
sep 
40 
M perambalur labourer no 
right 
foot 9.50 PM unidentified no 
pain 
11 
local no 
nil 
no no 
nil 
recovered 
345 
sep 
60 
M perambalur labourer no 
left 
ankle 
7:00 
AM unidentified no 
pain 
12 
local no 
nil 
no no 
nil 
recovered 
346 sep 43 M ariyalur farmer yes right leg 3.00 PM unidentified no pain 10 local no nil no no nil recovered  
347 
sep 
55 
M erode farmer yes  left leg  
8:30 PM unidentified no 
swelling / 
hematuria  >20 
haemotoxic  yes 
Bharat 
sr.O12039 
3hrs itching 
5 
recovered  
348 
sep 
58 
M perambalur labourer no 
right 
foot 5:45 PM unidentified no 
pain 
9 
local no 
nil 
no no 
nil 
recovered 
349 
sep 
35 
M ariyalur labourer yes 
right 
ankle 
11.10 
PM unidentified no 
pain 
10 
local no 
nil 
no no 
nil 
recovered  
350 
sep 
18 
M ariyalur student  yes 
right 
ankle 
11.35 
PM unidentified no 
pain 
11 
local no 
nil 
no no 
nil 
recovered  
351 
sep 
38 
M perambalur labourer no left foot 
6:15 
AM unidentified no 
pain 
12 
local no 
nil 
no no 
nil 
recovered 
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352 
oct 
14 
M ariyalur student yes left foot 
9.50 PM unidentified yes 
pain 
8 
local no 
nil 
no no 
nil 
recovered  
353 
oct 
21 
M perambalur labourer no 
left 
thumb 2:35 PM unidentified no 
pain 
8 
local no 
nil 
no no 
nil 
recovered 
354 oct 20 M perambalur labourer no left foot 6:00 PM unidentified no pain 11 local no nil no no nil recovered 
355 
oct 
50 
M perambalur labourer no 
right 
index 
finger 7:00 PM unidentified no 
pain 
10 
local no 
nil 
no no 
nil 
recovered 
356 
oct 
50 
M perambalur labourer yes left foot 
8:00 PM unidentified no 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
A1602116 
1hr no 
8 
recovered 
357 
oct 
13 
M perambalur student no 
right 
foot 6:20 PM unidentified no 
pain 
6 
local no 
nil 
no no 
nil 
recovered 
358 
oct 
53 
M perambalur labourer no 
left 
ankle 4:40 PM unidentified no 
pain 
8 
local no 
nil 
no no 
nil 
absconded 
359 
oct 
15 
F perambalur student yes right leg  
4:18 PM unidentified no 
pain 
>20 
local yes 
Biological E 
limited 
A1602116 
1hr no 
8 
recovered 
360 
oct 
53 
M perambalur labourer no 
left 
lower 
limb 2:00 PM unidentified no 
pain 
5 
local no 
nil 
no no 
nil 
absconded 
361 
oct 
65 
M perambalur labourer yes 
right 
foot  
8:00 PM unidentified yes 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
A1602116 
1hr 
nausea, 
vomiting, 
itching 13 
recovered 
362 
oct 
65 
M perambalur labourer no 
right 
foot 
11:50 
PM unidentified no 
pain 
11 
local no 
nil 
no no 
nil 
recovered 
363 
oct 
60 
F perambalur labourer yes 
right 
forearm 
8:00 PM unidentified no 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
A1602116 
1hr 
nausea, 
vomiting 
10 
recovered 
364 
oct 
55 
M erode farmer yes  right leg  
10:00 
AM R.viper  no 
pain, 
swelling 
10 
local yes 
Bharat 
sr.O+Q434120
39+Q506+Q52
4 
1hr no 
5 
recovered  
365 
oct 
35 
M perambalur labourer yes 
left 
lower 
limb 2:45 PM unidentified no 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
A1602116 
1hr 
nausea, 
vomiting, 
itching 8 
recovered 
366 
oct 
40 
F perambalur labourer yes 
right 
ankle 
7:50 PM unidentified no 
swelling 
>20 
haemotoxic  yes 
Biological E 
limited 
A1602116 
1hr 
yes. , 
anaphylax
is 8 
recovered 
367 
oct 
60 
F perambalur labourer yes left foot 
3.00 PM unidentified no 
pain, 
swelling, 
lymphade
nopathy >20 
haemotoxic  yes 
Biological E 
limited 
A1602116 
1hr 
yes. 
itching, 
urticaria 
5 
recovered 
368 
oct 
30 
M perambalur labourer no 
left 
thumb 6:00 PM unidentified no 
pain 
14 
local no 
nil 
no no 
nil 
recovered 
369 
oct 
40 
F perambalur labourer no 
right 
ankle 
7:00 
AM unidentified no 
pain 
11 
local no 
nil 
no no 
nil 
recovered 
370 
oct 
19 
M perambalur student no 
left 
lower 
limb 
7:00 
AM unidentified yes 
pain 
10 
local no 
nil 
no no 
nil 
recovered 
371 
oct 
35 
M perambalur labourer no left foot 
10:30 
PM unidentified no 
pain 
12 
local no 
nil 
no no 
nil 
recovered 
372 
oct 
37 
M perambalur labourer no 
left 
ankle 8:55 PM unidentified no 
pain 
10 
local no 
nil 
no no 
nil 
recovered 
373 
oct 
35 
M perambalur labourer yes 
right 
foot 5:30 PM unidentified yes 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
1hr 
anaphylax
is  10 
recovered 
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A1602116 
374 
oct 
52 
F perambalur labourer no 
left 
forearm 7:45 PM unidentified no 
pain 
11 
local no 
nil 
no no 
nil 
recovered 
375 
oct 
35 
M perambalur labourer yes right leg 
3:30 PM unidentified no 
pain, 
swelling 
>20 
haemotoxic  yes 
Biological E 
limited 
A1602116 
1hr 
yes, 
itching 
13 
recovered 
376 
oct 
53 
M perambalur labourer no 
right 
foot 7:15 PM unidentified no 
pain 
8 
local no 
nil 
no no 
nil 
recovered 
377 
oct 
40 
M perambalur labourer yes left foot 
7:45 PM unidentified no 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
A1602116 
1hr urticaria 
18 
recovered 
378 
oct 
60 
M perambalur labourer no 
left 
thumb 3:30 PM unidentified no 
pain 
10 
local no 
nil 
no no 
nil 
recovered 
379 
oct 
19 
M perambalur labourer yes left foot 
8:00 PM unidentified no 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
A1602116 
1hr 
yes,itchin
g 
10 
recovered 
380 
oct 
52 
M perambalur farmer yes 
right 
index 
finger 7:45 PM unidentified no 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
A1602116 
1hr 
yes, 
itching 
16 
recovered 
381 
oct 
29 
M perambalur labourer yes 
right 
ankle 
10:30 
PM unidentified no 
pain, 
swelling 
>20 
haemotoxic  yes 
Biological E 
limited 
A1602116 
1hr 
yes. 
itching , 
urticaria 8 
recovered 
382 
oct 
59 
M perambalur labourer no left foot 
8:55 PM unidentified yes 
pain 
12 
local no 
nil 
no no 
nil 
recovered 
383 
oct 
20 
F perambalur labourer yes 
right big 
toe 
5:30 PM unidentified no 
pain, 
dyspnea, 
ophthalm
oplegia >20 
neurotoxic yes 
Biological E 
limited 
A1602116 
1hr itching 
26 
recovered 
384 
oct 
17 
M perambalur labourer yes left foot 
2:45 PM unidentified no 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
A1602116 
1hr 
yes, 
itching 
8 
recovered, 
absconded 
385 
oct 
47 
M perambalur labourer no left leg 
7:50 PM unidentified no 
pain 
9 
local no 
nil 
no no 
nil 
recovered 
386 
oct 
15 
M perambalur labourer no 
left 
lower 
limb 3.00 PM unidentified no 
pain 
11 
local no 
nil 
no no 
nil 
recovered 
387 
oct 
28 
M erode labourer yes  left leg  
6:00 
AM unidentified no 
swelling 
/blisters  >20 
haemotoxic  yes 
Bharat 
sr.O12039 
2hrs itching 
6 
recovered  
388 
oct 
42 
M perambalur labourer no 
right 
ankle 
7:00 
AM unidentified no 
pain 
8 
local no 
nil 
no no 
nil 
recovered 
389 
oct 
55 
M perambalur labourer no 
left big 
toe 4:30 PM unidentified no 
pain 
10 
local no 
nil 
no no 
nil 
recovered 
390 
oct 
36 
M perambalur labourer yes 
left 
ankle 
5:00 
AM unidentified no 
pain, 
blisters 
>20 
haemotoxic  yes 
Biological E 
limited 
A1602116 
1hr 
yes. 
urticaria 
8 
recovered 
391 
oct 
40 
F perambalur labourer no 
left 
ankle 7.50 PM unidentified no 
pain 
10 
local no 
nil 
no no 
nil 
absconded 
392 
oct 
32 
F perambalur housewife no 
left 
thumb 8.30AM unidentified no 
pain 
12 
local no 
nil 
no no 
nil 
recovered 
393 oct 29 M perambalur labourer no left foot 6:00 PM unidentified no pain 11 local no nil no no nil recovered 
394 
oct 
2 
M perambalur nil no 
right big 
toe 7:45 PM unidentified no 
pain 
13 
local no 
nil 
no no 
nil 
absconded 
395 
oct 
55 
F perambalur labourer yes 
right 
ankle 
3:30 PM unidentified no 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
A1602116 
1hr giddines 
8 
recovered 
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396 
oct 
37 
M perambalur labourer no 
right 
index 
finger 6:00 PM unidentified no 
pain 
12 
local no 
nil 
no no 
nil 
recovered 
397 
oct 
40 
F perambalur labourer no 
left 
thumb 2:45 PM unidentified yes 
pain 
11 
local no 
nil 
no no 
nil 
recovered 
398 
oct 
55 
M perambalur labourer yes 
right 
forearm 7:50 PM unidentified no 
pain 
15 
local no 
nil 
no no 
nil 
recovered 
399 
oct 
37 
M perambalur labourer yes 
right 
foot  
3.00 PM C.krait no 
giddiness,
ptosis,dro
wsiness 14 
neurotoxic yes 
Biological E 
limited 
A1602116 
45 mins  no 
24 
death due to 
respiratory 
failure 
400 
oct 
50 
M perambalur labourer yes right leg  
8:00 PM unidentified yes 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
A1602116 
1hr no 
5 
recovered 
401 
oct 
40 
M perambalur labourer no 
left 
lower 
limb 7:45 PM unidentified no 
pain 
10 
local no 
nil 
no no 
nil 
absconded 
402 
oct 
36 
F perambalur labourer yes left leg 10:30 
PM unidentified no 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
A1602116 
1hr no 
8 
recovered 
403 
oct 
25 
M perambalur labourer no 
left 
ankle 8:55 PM unidentified no 
pain 
15 
local no 
nil 
no no 
nil 
recovered 
404 
oct 
56 
F perambalur labourer no 
right 2th 
toe 5:30 PM unidentified no 
pain 
14 
local no 
nil 
no no 
nil 
recovered 
405 
oct 
42 
M perambalur labourer no 
right 
ankle 
2:00 
AM unidentified no 
pain 
11 
local no 
nil 
no no 
nil 
recovered 
406 
nov 
35 
M erode driver yes 
unknow
n  2:45 PM unidentified no 
pain 
>20 
haemotoxic  yes 
Bharat 
sr.4053160 
30 mins no 
12 
recovered  
407 
nov 
40 
M perambalur labourer yes 
left 
thumb 
8:55 PM unidentified yes 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
AS16003 
1hr no 
8 
recovered 
408 
nov 
50 
M perambalur labourer no 
right 
ankle 5:30 PM unidentified no 
pain 
10 
local no 
nil 
no no 
nil 
recovered 
409 nov 45 F perambalur labourer no left foot 6:00 PM unidentified no pain 14 local no nil no no nil absconded 
410 
nov 
32 
M perambalur labourer yes right leg 10:30 
PM unidentified no 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
AS16003 
1hr no 
13 
recovered 
411 
nov 
57 
M perambalur labourer yes left foot 
8:55 PM unidentified no 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
AS16003 
1hr no 
8 
recovered 
412 nov 32 M perambalur labourer no left foot 5:30 PM unidentified no pain 11 local no nil no no nil recovered 
413 
nov 
33 
M perambalur labourer yes 
right big 
toe 
7:45 PM unidentified no 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
AS16003 
1hr no 
13 
recovered 
414 
nov 
57 
M perambalur labourer no right leg 
3:30 PM unidentified no 
pain 
12 
local no 
nil 
no no 
nil 
recovered 
415 
nov 
62 
M perambalur labourer no 
left big 
toe 7:15 PM unidentified no 
pain 
11 
local no 
nil 
no no 
nil 
recovered 
416 nov 80 M perambalur labourer no left foot 8:55 PM unidentified no pain 10 local no nil no no nil recovered 
417 
nov 
58 
M perambalur labourer yes 
left 
lower 
limb 5:30 PM unidentified no 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
AS16003 
1hr no 
18 
recovered 
418 
nov 
23 
M perambalur student yes left leg 
6:20 PM unidentified no 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
AS16003 
1hr no 
8 
recovered 
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419 
nov 
13 
M perambalur student yes left leg 
4:40 PM unidentified no 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
AS16003 
1hr no 
5 
recovered 
420 
nov 
35 
M perambalur labourer yes left foot 
4:18 PM unidentified no 
ptosis, 
dysphagia 
>20 
neurotoxic yes 
Biological E 
limited 
AS16003 
1hr no 
16 
recovered 
421 
nov 
25 
F perambalur housewife yes 
left 
thumb 
2:00 PM unidentified yes 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
AS16003 
1hr no 
8 
recovered 
422 
nov 
55 
M perambalur labourer no 
left 
ankle 8:00 PM unidentified yes 
pain 
12 
local no 
nil 
no no 
nil 
recovered 
423 
nov 
25 
F perambalur housewife yes 
right 
ankle 
11:50 
PM unidentified no 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
AS16003 
1hr no 
8 
recovered 
424 
nov 
35 
M perambalur labourer yes 
right 
foot  
6:25 PM unidentified no 
pain, 
hypotensi
on >20 
haemotoxic  yes 
Biological E 
limited 
AS16003 
1hr no 
8 
recovered 
425 
nov 
40 
M erode labourer yes 
unknow
n  2:10 PM unidentified no 
ptosis, 
dysphagia 15 
neurotoxic yes 
Bharat 
sr.4053160 
30 mins no 
14 
recovered  
426 nov 50 M perambalur labourer no left foot 3:00 PM unidentified no pain 9 local no nil no no nil recovered 
427 
nov 
70 
M perambalur labourer no 
right 
ankle 6:00 PM unidentified no 
pain 
11 
local no 
nil 
no no 
nil 
recovered 
428 
nov 
40 
F perambalur labourer no 
left 
ankle 4:00 PM unidentified no 
pain 
14 
local no 
nil 
no no 
nil 
recovered 
429 
nov 
55 
M erode labourer yes  right leg  5:45 
AM unidentified no 
swelling 
/blisters 
/bleeding  >20 
haemotoxic  yes Bharat 
sr.4053140 
30 mins no 
8 
recovered  
430 
nov 
62 
M perambalur labourer yes left foot 6:00 
AM unidentified no 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
AS16003 
1hr no 
5 
recovered 
431 
nov 
65 
M perambalur labourer no 
right 
ankle 
7:00 
AM unidentified no 
pain 
8 
local no 
nil 
no no 
nil 
recovered 
432 
nov 
35 
F perambalur housewife no 
left 
lower 
limb 6:20 PM unidentified yes 
pain 
9 
local no 
nil 
no no 
nil 
absconded 
433 
nov 
60 
M perambalur labourer no left foot 
4:40 PM unidentified no 
pain 
7 
local no 
nil 
no no 
nil 
recovered 
434 
nov 
4 
M perambalur nil no 
left 
forearm 4:18 PM unidentified no 
pain 
4 
local no 
nil 
no no 
nil 
recovered 
435 
nov 
37 
F perambalur labourer yes 
left 
ankle 
2:00 PM unidentified yes 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
AS16003 
1hr no 
10 
recovered 
436 
nov 
17 
F perambalur student no 
right 
index 
finger 8:00 PM unidentified no 
pain 
14 
local no 
nil 
no no 
nil 
recovered 
437 
nov 
26 
F perambalur housewife yes 
right 
ankle 
11:50 
PM unidentified no 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
AS16003 
1hr no 
5 
recovered 
438 
nov 
15 
M perambalur labourer yes left foot 
4:30 PM unidentified no 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
AS16003 
1hr no 
8 
recovered 
439 
nov 
23 
F perambalur housewife no 
left 
thumb 
5:00 
AM unidentified no 
pain 
8 
local no 
nil 
no no 
nil 
recovered 
440 
nov 
28 
F perambalur labourer no 
right big 
toe 7.50 PM unidentified no 
pain 
5 
local no 
nil 
no no 
nil 
recovered 
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441 
nov 
45 
M perambalur labourer yes 
right 
foot 
8.30AM unidentified no 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
AS16003 
1hr no 
16 
recovered 
442 
nov 
48 
F perambalur labourer yes left foot 
8:55 PM unidentified yes 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
AS16003 
1hr no 
8 
recovered 
443 
nov 
45 
M perambalur labourer no 
left 
lower 
limb 5:30 PM unidentified yes 
pain 
8 
local no 
nil 
no no 
nil 
recovered 
444 
nov 
28 
F perambalur housewife no 
right 
ankle 6:00 PM unidentified no 
pain 
9 
local no 
nil 
no no 
nil 
recovered 
445 
nov 
47 
M erode labourer yes  
right 
middle 
finger  6:00 PM unidentified no 
pain, 
swelling 
12 
local yes Bharat 
sr.4053140 
3hrs no 
3 
recovered  
446 
nov 
12 
F perambalur labourer yes 
left 
ankle 
10:30 
PM unidentified no 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
A160696 
1hr no 
8 
recovered 
447 
nov 
40 
M perambalur labourer yes 
left big 
toe 
8:55 PM unidentified no 
cellulitis 
>20 
haemotoxic  yes 
Biological E 
limited 
A160696 
1hr no 
8 
recovered 
448 
nov 
39 
M perambalur labourer no 
right 
ankle 5:30 PM unidentified no 
pain 
10 
local no 
nil 
no no 
nil 
recovered 
449 
nov 
28 
M perambalur labourer no left foot 
7:45 PM unidentified no 
pain 
15 
local no 
nil 
no no 
nil 
recovered 
450 
nov 
32 
F perambalur labourer no 
right big 
toe 3:30 PM unidentified no 
pain 
1 
local no 
nil 
no no 
nil 
recovered 
451 
nov 
28 
F perambalur labourer no 
right 
index 
finger 7:15 PM unidentified no 
pain 
8 
local no 
nil 
no no 
nil 
recovered 
452 
nov 
36 
F perambalur labourer yes 
left big 
toe 
2:45 PM unidentified no 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
A160696 
1hr no 
13 
recovered 
453 
nov 
27 
M perambalur labourer yes 
left 
thumb 
7:50 PM unidentified no 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
A160696 
1hr no 
13 
recovered 
454 
nov 
24 
M perambalur labourer yes right leg  
3.00 PM unidentified yes 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
A160696 
1hr no 
13 
recovered 
455 
nov 
26 
M perambalur labourer yes right leg  
8:55 PM unidentified yes 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
A160696 
1hr no 
8 
recovered 
456 
nov 
26 
M perambalur labourer yes 
left 
lower 
limb 5:30 PM unidentified no 
pain 
9 
local no 
nil 
no no 
nil 
recovered 
457 
nov 
45 
M erode labourer no 
unknow
n  
11.30 
AM R.viper  no 
swelling 
15 
minu
tes  
local yes Bharat 
sr.4053160 
2hrs no 
14 
recovered  
458 nov 36 M perambalur labourer no right leg 6:20 PM unidentified yes pain 11 local no nil no no nil recovered 
459 
nov 
21 
M perambalur labourer no 
left 
thumb 4:40 PM unidentified no 
pain 
10 
local no 
nil 
no no 
nil 
recovered 
460 
nov 
55 
M perambalur labourer no left foot 
4:18 PM unidentified no 
pain 
9 
local no 
nil 
no no 
nil 
recovered 
461 
dec 
75 
M perambalur labourer no 
left 
ankle 2:00 PM unidentified no 
pain 
7 
local no 
nil 
no no 
nil 
recovered 
462 
dec 
65 
M perambalur labourer no 
left 
forearm 8:00 PM unidentified no 
pain 
8 
local no 
nil 
no no 
nil 
recovered 
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463 
dec 
42 
F erode farmer yes  left foot  
8:30 PM unidentified no 
swelling 
>20 
haemotoxic  yes 
Bharat 
sr.Q52421200
8 
30 mins no 
5 
recovered  
464 
dec 
50 
F perambalur labourer yes left foot 
8:20 PM unidentified no 
cellulitis 
>20 
haemotoxic  yes 
Biological E 
limited 
A160696 
1hr 
yes. 
itching 
followed 
by 
anaphylax
is 13 
recovered 
465 
dec 
60 
M perambalur labourer yes 
left 
thumb 
8:00 
AM unidentified no 
pain 
>20 
haemotoxic  yes 
Biological E 
limited 
A160696 
1hr no 
8 
recovered 
466 
dec 
65 
F perambalur labourer no 
left 
lower 
limb 
7:00 
AM unidentified no 
pain 
>20 
local no 
nil 
no no 
nil 
recovered 
467 
dec 
47 
M perambalur labourer yes 
right 
index 
finger 4:30 PM unidentified no 
drowsines
s, 
dysphagia >20 
neurotoxic yes bio vins 
01AS15040 
1hr no 
18 
recovered 
468 
dec 
37 
F perambalur labourer yes 
right 
forearm 
5:00 
AM unidentified no 
cellulitis 
>20 
haemotoxic  yes 
bio vins 
01AS15040 
1hr no 
13 
recovered 
469 
dec 
57 
M perambalur labourer yes left foot 
7.50 PM unidentified no 
pain 
>20 
haemotoxic  yes 
bio vins 
01AS15040 
1hr no 
13 
recovered 
470 
dec 
21 
M perambalur labourer no left foot 
8.30AM unidentified no 
pain 
9 
local no 
nil 
no no 
nil 
recovered 
471 
dec 
40 
M perambalur labourer no 
right 
ankle 6:00 PM unidentified no 
pain 
7 
local no 
nil 
no no 
nil 
recovered 
472 
dec 
45 
F perambalur labourer no 
left 
lower 
limb 6:00 PM unidentified yes 
pain 
8 
local no 
nil 
no no 
nil 
recovered 
473 
dec 
11 
M erode student yes  
right 
third toe 2:00 PM unidentified no 
pain, 
swelling >20 
haemotoxic  yes 
Bharat 
sr.212008 
30 mins 
itching, 
giddiness 7 
recovered  
474 
dec 
35 
F erode farmer yes  
right 
foot  
9.30 
AM  unidentified no 
pain, 
swelling 9 
local yes 
Bharat 
sr.4053140 
6hrs itching 
6 
recovered  
475 
dec 
32 
M erode labourer yes  
right 
hand  3:30 PM unidentified no 
pain, 
swelling 10 
local yes 
Bharat 
sr.4053140 
3hrs no 
7 
recovered  
476 
dec 
28 
F erode housewife yes  left hand  11:00 
AM unidentified no 
pain, 
swelling , 
blisters  7 
local yes Bharat 
sr.4053140 
1hr no 
2 
recovered  
 
 
 
 
 
 
 
 
  
ANNEXURE IIb: PROFORMA 
 
DEMOGRAPHIC PROFILE DATE  
Age/Sex :                    Occupation:                 Type Of Snake*: 
Time Of Snake Bite:                    Site Of Bite:                       
CLINICAL PARAMETERS  Systemic envenomation 
o Ptosis 
o Drowsiness 
o Visual disturbances 
o Dyspnea, dysphagia 
o Hypotension 
o Bleeding  
o Haematuria/Oliguria/anuria 
INITIAL CLINICAL PRESENTATION 
 Local envenomation 
o  Swelling 
o Blisters / bullae 
o lymphadenopathy 
○   Haemotoxic        ○  Neurotoxic       ○ other(specify)*: 
INVESTIGATIONS   Initial WBCT :  
Other positive data(if any): 
 
TIME OF ASV ADMINISTRATION  
REACTIONS WHILE ON ASV YES /NO 
EARLY  PYROGENIC LATE 
o Itching  
o Urticaria 
o Fever 
o Nausea,vomiting 
o Anaphylaxis 
(hypotension 
,bronchospasm 
,angioedema) 
o Chills 
o Rigor  
o hypotension 
o fever 
o nausea, vomiting 
o arthralgia 
o recurrent urticaria 
o myalgia 
o lymphadenopathy 
o proteinuria 
 
OUTCOME OF REACTION 
○  FATAL           ○  RECOVERED            ○ REQUIRED INTERVENTION  
TRANSFUSION* (if any) :    
OTHER SPECIFIC REACTIONS *(if any): 
TOTAL DOSE OF ASV ADMINISTERED         +      +      +      +     + 
COMMENTS (if any) : Details of ASV used :  
 
 
  
ANNEXURE IIc: LIVERPOOL ALGORITHM 
 
LIVERPOOL AL                                                       No 
    
              Yes      No 
  
No No 
 
              Yes  
                                                   Yes 
     
                                                  No        No 
 
Yes or Unassessable*      Yes No 
  
 High or                                                                                                         No 
                                            Unsure  
        Low 
 
 No     No 
 
      Yes      Yes 
 Yes 
 
  
 
 
 
ANNEXURE IId: ADR severity assessment scale 
   
Unlikely 
Do you suspect any 
adverse drug reaction? 
 
Did the event appear after 
the drug was administered 
or dose increased? 
Were pre-existing symptoms 
exacerbated by the drug? 
Did the event improve (± 
treatment) when the drug 
was stopped or dose 
reduced? 
What is the probability that 
the event was due to an 
underlying disease? 
Was there a  positive 
rechallenge? 
Definite 
 
Possible 
Was the event associated 
with long lasting disability 
or impairment? 
**Is there any objective 
evidence of the causal ADR 
mechanism? 
Is there a past history of the 
same event with this drug in 
this patient? 
Has the event previously 
been reported with this drug? 
Probable 
 
* Unassessable refers to situations where the medicine is administered on one occasion (e.g. Vaccine), the patient 
receives intermittent therapy(e.g. Chemotherapy), or is on medicationwhich cannot be stopped(e.g. 
Immunosuppressants)** Examples of objective evidence: Positive laboratory investigations of the causal ADR 
mechanism(Not those merely confirming the adverse reaction), Supra-therapeutic drug levels, good evidence of dose-
dependent relationship with toxicity in the patient  
 
 
  
ANNEXURE IId: ADR Severity Assessment Tool 
(Modified Hartwig and Siegel) 
 
 
MILD 
Level I: The ADR requires no change in treatment with the suspected drug. 
 
OR 
 
Level II:  The ADR requires that the suspected drug be withheld, discontinued or 
otherwise changed. No antidote or other treatment is required, and there is no increase in 
lenght of stay. 
 
MODERATE 
Level III: The ADR requires that the suspected drug be withheld, discontinued or otherwise 
changed, and/ or an antidote or other treatment is required. There is no increase in lenght of 
stay. 
 
OR 
 
Level IV (a): Any level 3 ADR that increases lenght of stay by at least one day. 
 
OR 
 
Level IV (b): The ADR is the reason for admission. 
 
SEVERE 
Level V: Any level 4 ADR that requires intensive medical care. 
 
OR 
 
Level VI: The ADR causes parmanent harm to the patient. 
 
OR 
 
Level VII: The ADR either directly or indirectly leads to the death of the patient 
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